<SEC-DOCUMENT>0001437749-24-021339.txt : 20240627
<SEC-HEADER>0001437749-24-021339.hdr.sgml : 20240627
<ACCEPTANCE-DATETIME>20240627084514
ACCESSION NUMBER:		0001437749-24-021339
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20240627
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240627
DATE AS OF CHANGE:		20240627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Genprex, Inc.
		CENTRAL INDEX KEY:			0001595248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				900772347
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38244
		FILM NUMBER:		241075538

	BUSINESS ADDRESS:	
		STREET 1:		1601 TRINITY STREET, BLDG. B
		STREET 2:		SUITE 3.322
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78712
		BUSINESS PHONE:		512-537-7997

	MAIL ADDRESS:	
		STREET 1:		1601 TRINITY STREET, BLDG. B
		STREET 2:		SUITE 3.322
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78712
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gnpx20240507_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:gnpx="http://www.gnpx.com/20240627"><head>
	<title>gnpx20240507_8k.htm</title>

	<!-- Created by RDG Portal -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-right: 10px; margin-left: 10px; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20248K" name="dei:AmendmentFlag" id="ixv-298">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20248K" name="dei:EntityCentralIndexKey" id="ixv-299">0001595248</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="gnpx-20240627.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20248K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001595248</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-06-27</xbrli:startDate>
<xbrli:endDate>2024-06-27</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt 7.2pt;text-align:center;"><b>UNITED STATES</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt 7.2pt;text-align:center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>Washington, D.C. 20549</b>&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&#160; &#160;</div>

<div style="background-color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;line-height:.15;margin:0pt 7.2pt;text-align:center;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt 7.2pt;text-align:center;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt 7.2pt;text-align:center;"><b>FORM <ix:nonNumeric contextRef="d20248K" name="dei:DocumentType" id="ixv-18"><b><b><b><b>8-K</b></b></b></b></ix:nonNumeric></b>&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&#160; &#160;&#160;</div>

<div style="background-color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;line-height:.15;margin:0pt 7.2pt;text-align:center;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>PURSUANT TO SECTION 13 OR 15(d)</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-34"><span style="text-decoration: underline;"><b>June 27, 2024</b></span></ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">Date of report (Date of earliest event reported)</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt 7.2pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityRegistrantName" id="ixv-40"><span style="text-decoration: underline;"><b>GENPREX, INC.</b></span></ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>(Exact name of registrant as specified in its charter)</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;"><b>&#160;</b></div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-52"><span style="text-decoration: underline;"><b>Delaware</b></span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:29.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityFileNumber" id="ixv-57"><span style="text-decoration: underline;"><b>001-38244</b></span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityTaxIdentificationNumber" id="ixv-62"><span style="text-decoration: underline;"><b>90-0772347</b></span></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(State or other jurisdiction of</div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">incorporation or organization)</div>
			</td>
			<td style="vertical-align:top;width:29.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Commission File Number)</div>
			</td>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(I.R.S. Employer</div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Identification Number)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:35%;">&#160;</td>
			<td style="vertical-align:top;width:29.9%;">&#160;</td>
			<td style="vertical-align:middle;width:35%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><span style="text-decoration: underline;"><b><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressAddressLine1" id="ixv-83"><span style="text-decoration: underline;"><b><span style="text-decoration: underline;"><b>3300 Bee Cave Road, #650-227</b></span></b></span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressCityOrTown" id="ixv-88"><span style="text-decoration: underline;"><b><span style="text-decoration: underline;"><b>Austin</b></span></b></span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressStateOrProvince" id="ixv-93"><span style="text-decoration: underline;"><b><span style="text-decoration: underline;"><b><span style="text-decoration: underline;"><b>TX</b></span></b></span></b></span></ix:nonNumeric></b></span></div>
			</td>
			<td style="vertical-align:top;width:29.9%;">&#160;</td>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressPostalZipCode" id="ixv-103"><span style="text-decoration: underline;"><b>78746</b></span></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Address of principal executive offices)</div>
			</td>
			<td style="vertical-align:top;width:29.9%;">&#160;</td>
			<td style="vertical-align:middle;width:35%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Zip Code)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Registrant&#8217;s telephone number, including area code: <span style="text-decoration: underline;"><b>(<ix:nonNumeric contextRef="d20248K" name="dei:CityAreaCode" id="ixv-116"><span style="text-decoration: underline;"><b><span style="text-decoration: underline;"><b>512</b></span></b></span></ix:nonNumeric>) <ix:nonNumeric contextRef="d20248K" name="dei:LocalPhoneNumber" id="ixv-121"><span style="text-decoration: underline;"><b><span style="text-decoration: underline;"><b>537-7997</b></span></b></span></ix:nonNumeric></b></span></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-309">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:94.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-310">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:94.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-311">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:94.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-312">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:94.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Securities registered pursuant to Section&#160;12(b) of the Act:</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:37.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Title of each class</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom: 1px #000000;;width:1.3%;">&#160;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:15%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Trading</b></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Symbol(s)</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom: 1px #000000;;width:1.3%;">&#160;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:44.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:37.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:Security12bTitle" id="ixv-313">Common Stock</ix:nonNumeric>, par value $0.001 per share</div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:1.3%;">&#160;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:15%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:TradingSymbol" id="ixv-314">GNPX</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:1.3%;">&#160;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:44.7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">The <ix:nonNumeric contextRef="d20248K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-315">Nasdaq</ix:nonNumeric> Capital Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b&#8211;2 of the Securities Exchange Act of 1934 (&#167; 240.12b&#8211;2 of this chapter).</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Emerging growth company&#160;<ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-316">&#9744;</ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Item 7.01&#160;Regulation FD Disclosure.</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: left;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Press Release &amp; Stockholder Update</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On June 27, 2024, Genprex, Inc. (the &#8220;Company&#8221;) issued a press release announcing the issuance of a stockholder letter and corporate update.&#160;The full text of the press release and the stockholder letter and corporate update is attached to this Current Report on Form 8-K as Exhibit 99.1.&#160;The press release including stockholder letter&#160;and corporate update that is furnished as Exhibit 99.1&#160;to this Current Report on Form 8-K will be available on the Company&#8217;s website, <span style="text-decoration: underline;">www.genprex.com</span>.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The information in this Current Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by a specific reference in such filing.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Item 9.01&#160;Financial Statements and Exhibits.</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">(d) Exhibits.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:8.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Exhibit</b></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Number</b></div>
			</td>
			<td style="vertical-align:bottom;width:4.8%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&#160;</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:86.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&#160;Description</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:8.9%;">&#160;</td>
			<td style="vertical-align:middle;width:4.8%;">&#160;</td>
			<td style="vertical-align:middle;width:86.2%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; text-align: center;">99.1</td>
			<td style="vertical-align:middle;width:4.8%;">&#160;</td>
			<td style="vertical-align:middle;width:86.2%;"><a href="ex_669041.htm" style="-sec-extract:exhibit;">Press Release dated June 27, 2024, issued by Genprex, Inc.</a></td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:8.9%;">&#160;</td>
			<td style="vertical-align:middle;width:4.8%;">&#160;</td>
			<td style="vertical-align:middle;width:86.2%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 8.9%; text-align: center;">104</td>
			<td style="vertical-align:middle;width:4.8%;">&#160;</td>
			<td style="vertical-align:middle;width:86.2%;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.3pt; text-align: center;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:55.1%;">&#160;</td>
			<td colspan="2" style="vertical-align:top;border-bottom: 1px #000000;;width:33.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>GENPREX, INC.</b></div>
			</td>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:11.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:55.1%;">&#160;</td>
			<td style="vertical-align:top;width:3.5%;">&#160;</td>
			<td style="vertical-align:top;width:29.6%;">&#160;</td>
			<td style="vertical-align:top;width:11.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:55.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Date: June 27, 2024</div>
			</td>
			<td style="vertical-align:top;width:3.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">By:</div>
			</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:29.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i>/s/ Ryan Confer</i></div>
			</td>
			<td style="vertical-align:top;width:11.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:55.1%;">&#160;</td>
			<td style="vertical-align:top;width:3.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:29.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Ryan Confer</div>
			</td>
			<td style="vertical-align:top;width:11.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 55.1%;">&#160;</td>
			<td style="vertical-align: top; width: 3.5%;">&#160;</td>
			<td style="vertical-align: top; width: 29.6%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Chief Executive Officer and Chief Financial Officer</div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(Principal Executive Officer and Principal Financial and Accounting Officer)</div>
			</td>
			<td style="vertical-align: top; width: 11.8%;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_669041.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_669041.htm</title>
	<!-- Generated by ThunderDome Portal - 6/27/2024 3:50:32 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><img alt="genp.jpg" src="genp.jpg"></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Genprex Issues Stockholder Letter and Provides 2024 Corporate Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>Company Achieves Multiple Clinical Development Milestones in 2024</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>Patient Treatment Continues in Three Lung Cancer Clinical Trials</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">AUSTIN, Texas &#8212; (June 27, 2024) &#8212; Genprex, Inc. (&#8220;Genprex&#8221; or the &#8220;Company&#8221;) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has issued a stockholder letter and corporate update summarizing the Company&#8217;s recent achievements across its clinical development programs and outlines key milestones for 2024 and beyond.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;Genprex continues to make progress across a number of areas critical to advancing our novel gene therapies in oncology and diabetes,&#8221; said Ryan Confer, President and Chief Executive Officer. &#8220;So far this year, we have opened enrollment and have begun treating patients in two new lung cancer clinical trials, while we continued to treat patients in a third lung cancer clinical trial. We have partnered with a large network of community-based oncology practices to broaden our clinical study reach. We have also expanded our preclinical programs into new therapeutic indications, presenting positive preclinical data supporting our technologies used in these programs at one of the largest and most attended cancer research conferences. In addition, we&#8217;ve strengthened our global intellectual property estate, which builds protection for our lead drug candidate. We look forward to achieving a number of important catalysts in the coming months that will further position Genprex as a leader in gene therapy.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To read the stockholder letter in its entirety, a digital copy of the Company&#8217;s stockholder letter can be found on the Company&#8217;s website,&nbsp;<u>www.genprex.com</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>About Genprex, Inc.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex&#8217;s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex&#8217;s oncology program utilizes its systemic, non-viral Oncoprex&#174; Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. The Company&#8217;s lead product candidate, Reqorsa&#174; Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Each of Genprex&#8217;s three lung cancer clinical programs has received a Fast Track Designation from the FDA for the treatment of that patient population, and Genprex&#8217;s SCLC program has received an FDA Orphan Drug Designation. Genprex&#8217;s diabetes gene therapy approach is comprised of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which can produce insulin but may be distinct enough from beta cells to evade the body&#8217;s immune system. In a similar approach, GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Interested investors and shareholders are encouraged to sign up for press releases and industry updates by visiting the&nbsp;Company Website, registering for&nbsp;Email Alerts&nbsp;and by following Genprex on Twitter, Facebook and LinkedIn.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Cautionary Language Concerning Forward-Looking Statements</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Genprex&#8217;s reports that it files from time to time with the Securities and Exchange Commission and which you should review, including those statements under &#8220;Item 1A &#8211; Risk Factors&#8221; in Genprex&#8217;s Annual Report on Form 10-K for the year ended December 31, 2023.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Because forward-looking statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: the appointment and transition of management personnel and other succession plan-related activities; Genprex&#8217;s ability to advance the clinical development, manufacturing and commercialization of its product candidates in accordance with projected timelines and specifications; the timing and success of Genprex&#8217;s clinical trials and regulatory approvals; the effect of Genprex&#8217;s product candidates, alone and in combination with other therapies, on cancer and diabetes; Genprex&#8217;s future growth and financial status, including Genprex&#8217;s ability to maintain compliance with the continued listing requirements of The Nasdaq Capital Market and to continue as a going concern and to obtain capital to meet its long-term liquidity needs on acceptable terms, or at all; Genprex&#8217;s commercial and strategic partnerships, including those with its third party vendors, suppliers and manufacturers and their ability to successfully perform and scale up the manufacture of its product candidates; and Genprex&#8217;s intellectual property and licenses.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">These forward-looking statements should not be relied upon as predictions of future events and Genprex cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by Genprex or any other person that Genprex will achieve its objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Genprex disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events, except as required by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Genprex, Inc.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(877) 774-GNPX (4679)</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>GNPX Investor Relations</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">investors@genprex.com&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>GNPX Media Contact</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Kalyn Dabbs</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">media@genprex.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">June 27, 2024</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dear Fellow Stockholders:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">It is with great sorrow that my first address to you as President and Chief Executive Officer of Genprex follows the unexpected passing of Genprex&#8217;s co-founder Rodney Varner, who passed away in May due to sudden complications after his courageous battle with cancer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Rodney co-founded Genprex in 2009, served on our board of directors since 2012 and served as President and CEO since 2016. Under Rodney&#8217;s leadership, Genprex became a publicly traded company in 2018, successfully completed two Phase 1 clinical trials, opened three additional clinical trials, expanded its intellectual property portfolio, exclusively licensed new novel gene therapy technologies and received three U.S. Food and Drug Administration Fast Track Designations and an Orphan Drug Designation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">I had the great pleasure of working alongside Rodney since Genprex was founded. Following Rodney&#8217;s diagnosis in 2022, we worked closely on all strategic programs and operations. Rodney&#8217;s tenacity to push Genprex forward while battling cancer himself was and continues to be a true inspiration. The loss of a dear friend and a strong leader who battled cancer reinforces for me personally, and for all of us, our Company&#8217;s shared passion and dedication to our mission. I saw first-hand how Rodney bravely took on his cancer diagnosis, as well as the sad reality of how cancer affects patients, families, friends and colleagues. It is a reminder of the &#8220;<b>why</b>&#8221; behind everything we do here at Genprex.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: center;"><img alt="our.jpg" src="our.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As I step into the role of President and CEO, I am comforted by the exceptional team we&#8217;ve assembled and the compelling science we continue to advance in oncology and diabetes therapies. I&#8217;m confident in and excited by the potential of our platforms and pipeline.&nbsp; Importantly, we believe we have a number of value-creating milestones and catalysts ahead of us for the remainder of the year as we continue on our mission to <i>advance </i>novel gene therapies for patients afflicted with cancer and diabetes<i>.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">While we are still grieving the loss of our co-founder and colleague, I am pleased that 2024 is off to a strong start for Genprex. We continue to make progress across a number of areas critical to advancing our fight against cancer and diabetes with our novel gene therapies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><u>A Robust Start to 2024 </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Genprex has already achieved a number of key milestones this year, including:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Opened enrollment and dosed the first patient in the Phase 2a expansion portion of the Acclaim-1 clinical study to treat non-small cell lung cancer (NSCLC).</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Expanded our preclinical programs into new therapeutic indications that include the study of TUSC2 and NPRL2, both tumor suppressor genes, through our academic research collaborators. These researchers:</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Presented positive preclinical data on the use of Reqorsa&#174;&nbsp;Immunogene Therapy and on NPRL2 gene therapy utilizing the Oncoprex&#174;&nbsp;Delivery System for lung cancer treatment at the 2024 American Association for Cancer Research (AACR) Annual Meeting.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Strengthened our global intellectual property estate with the issuance of a Notice of Patent Grant from the Korean Patent Office for a broad patent that covers the use of REQORSA in combination with anti-PD-1 and PD-L1 antibodies, a key layer of protection for our combination therapies with our lead product candidate, REQORSA.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Expanded Acclaim-3 clinical study trial sites through our collaboration with a large network of community-based oncology practices to broaden our study&#8217;s reach to non-academic sites.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Opened enrollment and dosed the first patient in the Phase 1 dose escalation portion of the Acclaim-3 clinical study to treat small cell lung cancer (SCLC).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><u>Gene Therapy in Oncology </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We are as passionate as ever about our work to improve the lives of patients suffering with lung cancer, which remains the leading cause of cancer deaths worldwide, and has an average five-year survival rate of 26.6 percent. According to the American Cancer Society, it is estimated that in 2024 there will be more than 234,000 new cases of lung cancer and more than 125,000 deaths from this disease in the U.S. With limited benefit from current therapies, we believe there is a significant unmet medical need for new treatments for NSCLC and SCLC in the U.S. and globally, and we believe REQORSA may be suitable for the majority of lung cancer patients. We are committed to challenging the status quo by developing our innovative new medicines in the quest to fight this deadly disease.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div style="text-align: center;"><img alt="lun.jpg" src="lun.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our lead therapeutic candidate, REQORSA (quaratusugene ozeplasmid), utilizes our unique, proprietary, non-viral ONCOPREX Delivery System, and it is being developed in combination with prominent, approved cancer drugs, including AstraZeneca&#8217;s Tagrisso&#174; (osimertinib), Merck &amp; Co.&#8217;s Keytruda&#174; (pembrolizumab) and Genentech, Inc.&#8217;s Tecentriq&#174; (atezolizumab) to treat NSCLC and SCLC. We are currently enrolling three clinical trials of REQORSA in lung cancer: Acclaim-1, Acclaim-2 and Acclaim-3. All three of our Acclaim clinical trials have received U.S. Food and Drug Administration (FDA) Fast Track Designation, and Acclaim-3 also has FDA Orphan Drug Designation for the treatment of SCLC.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i><u>Acclaim-1 </u></i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We are currently enrolling and treating patients in the Phase 2a dose expansion portion of our Phase&nbsp;1/2&nbsp;Acclaim-1&nbsp;clinical trial.&nbsp;The Acclaim-1&nbsp;trial is evaluating the combination of REQORSA and Tagrisso to treat patients with late-stage NSCLC who have activating EGFR mutations and disease progression after treatment with Tagrisso.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our Phase 2a expansion study follows the successful completion of the Phase 1 dose escalation portion of the study, which showed REQORSA was generally well tolerated with no dose limiting toxicities. Importantly, the results showed early signs of efficacy with some patients experiencing prolonged progression free survival and one patient having a partial response.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Phase 2a expansion portion is expected to enroll approximately 66 patients. Half of these patients will have received Tagrisso treatment only, and the other half will have received Tagrisso treatment and chemotherapy. This will be used to determine toxicity profiles of patients with different eligibility criteria, as well as efficacy, and other endpoints. Our team will conduct an interim analysis following the treatment of 19 patients in each cohort, and we expect to complete the cohort enrollments by the end of 2024, and thus we expect to report interim analyses in early 2025.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: right;">
<div><img alt="aclaim1.jpg" src="aclaim1.jpg"></div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">This expansion portion of this study will provide early insight into drug effectiveness and increase the likelihood of a successful randomized Phase 2b trial which will follow the expansion portion study.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i><u>Acclaim-2 </u></i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We are also currently enrolling and treating patients in the Phase 1 dose escalation portion of our Phase 1/2 Acclaim-2 clinical trial. The Acclaim-2 trial uses a combination of REQORSA and Keytruda in patients with late-stage NSCLC whose disease has progressed after treatment with Keytruda. Patients are currently being treated at the 0.06 mg/kg dose level in the first cohort of patients and, subject to Acclaim-2 Safety Review Committee approval, will be treated at increased dose levels of 0.09 mg/kg and 0.12 mg/kg. We expect enrollment in the dose escalation portion of the study to be completed in the second half of 2024. We will then initiate and evaluate patients in the Phase 2a expansion portion of the study at the maximum tolerated dose or recommended Phase 2 dose.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: right;"><img alt="aclaim2.jpg" src="aclaim2.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As with our Acclaim-1 study, the dose escalation portion of Acclaim-2 is expected to provide early insight into the drug&#8217;s effectiveness and will inform our dose for the dose expansion portion of the study.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><u>Acclaim-3</u></i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Finally, we are currently enrolling and treating patients in the Phase 1 dose escalation portion of our Phase 1/2 Acclaim-3 clinical trial. Our Acclaim-3 clinical trial uses a combination of REQORSA and Tecentriq as a maintenance therapy in patients with extensive stage small cell lung cancer (ES-SCLC) who did not develop tumor progression after receiving Tecentriq and chemotherapy as initial standard treatment. In this study, patients will be treated with REQORSA and Tecentriq until disease progression or unacceptable toxicity is experienced. Following completion of the Phase 1 dose escalation portion of the study, which we expect to complete during the second half of 2024, we expect to start the Phase 2 expansion portion in the second half of 2024.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We recently added multiple clinical trial sites to our Acclaim-3 study in collaboration with a large network of integrated, community-based oncology practices. With these expanded clinical trial sites, we believe we will be able to accelerate patient enrollment and increase patient access to our clinical trial outside of major urban or academic settings, ultimately growing our reach to more ES-SCLC patients who are currently limited by existing treatment options.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: right;"><img alt="acclaim3.jpg" src="acclaim3.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><u>2024 American Association of Cancer Research (AACR) Positive Preclinical Data</u></i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">At the recent 2024 AACR annual meeting in April, our research collaborators presented a bolus of positive preclinical data relating to REQORSA and to NPRL2 gene therapy, which both utilize our non-viral ONCOPREX Delivery System for the treatment of lung cancer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The first presentation, entitled &#8220;<u>Quaratusugene ozeplasmid mediated TUSC2 upregulation in EML4-ALK bearing Non-Small Cell Lung Carcinoma can induce cellular apoptosis</u>,&#8221;&nbsp;found that overexpressing TUSC2 using REQORSA treatment in ALK+ lung cancer cell lines inhibited the ability of the cells to form colonies. Additionally, researchers documented a strong pro-apoptotic response when TUSC2 was expressed in ALK+ NSCLC. Ultimately, the study found that the use of REQORSA or a TUSC2-containing plasmid to overexpress TUSC2 in ALK+ NSCLC cell lines was effective in decreasing cell growth and proliferation.&nbsp;Researchers believe the results support further clinical study of REQORSA as an anti-ALK NSCLC treatment strategy.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The second poster presentation, entitled &#8220;<u>TUSC2 suppresses energy metabolism in lung cancer cells with opposite effects in normal bronchial epithelial cells</u>,&#8221;&nbsp;showed that the TUSC2-deficient cancer cells treated to increase TUSC2 expression consistently exhibited decreased glycolytic rates and mitochondrial ATP production, leaving these cells without enough energy to support their vital functions. The study further suggested that REQORSA may play an important role as a cancer treatment to target and disrupt the metabolism of cancer cells, leading to a decrease in the rate of glycolysis.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The third poster presentation, entitled &#8220;<u>Mechanism of NPRL2 gene therapy&nbsp;induced&nbsp;anti-tumor&nbsp;immunity in KRAS/STK11<b><sup style="vertical-align:top;line-height:120%;">mt</sup></b>&nbsp;aPD1 resistant metastatic NSCLC</u>,&#8221;&nbsp;showed that the NPRL2 treatment decreased lung metastases, even in cell lines and mouse xenografts where pembrolizumab had no effect. Researchers also found a greater anti-tumor effect when comparing the humanized mice, which have a human immune system, to non-humanized mice, which have immune deficiencies, demonstrating that immune cells play a role in the effects of the NPRL2 nanoparticle therapy.&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We believe all three studies were significant as they validated the life-changing potential of REQORSA as an innovative cancer treatment and further supported the use of ONCOPREX as a Delivery Platform. We are excited to continue to advance the study of REQORSA and NPRL2 as potential cancer treatments utilizing our non-viral delivery system.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><u>Expansion of Nonclinical Programs in New Therapeutic Indications </u></i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Earlier this year, we announced our plans to expand our nonclinical programs to include new indications through Sponsored Research Agreements and Material Transfer Agreements with multiple academic research collaborators to study TUSC2 and NPRL2. Our expansion plans include programs with TUSC2 in ALK-EML4 positive translocated lung cancer (a subset of NSCLC that impacts young and relatively healthy individuals) at the University of Michigan Rogel Cancer Center, with TUSC2 in metabolism at Meharry Medical College in Nashville, Tennessee, and with NPRL2 in lung cancers with a major cancer research center in Houston, Texas. These initiatives allow us the potential to move into ALK-positive NSCLC, KRAS/STK11 mutant NSCLC and other additional programs where our technology has the potential to improve the lives of patients battling lung cancers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Gene Therapy for Diabetes </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As with cancer, we believe diabetes represents a significant market opportunity with great unmet medical need where patients are underserved by current treatment options. According to the U.S. Center for Disease Control, as of 2023, 38.4 million Americans, or approximately 11.6% of the U.S. population, have diabetes. Also in 2021, diabetes caused more than 6.7 million deaths globally and diabetes resulted in approximately $966 billion dollars in health expenditures, a 316% increase over the preceding fifteen years. We are committed to advancing disruptive and innovative treatment options to patients suffering from this global health epidemic.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We have exclusively licensed multiple technologies relating to the development of a gene therapy product for both Type 1 diabetes (T1D) and Type 2 diabetes (T2D) from the University of Pittsburgh of the Commonwealth System of Higher Education (UPitt).&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</div>

<div class="hf-cell PGNUM" style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our innovative diabetes gene therapy program utilizes an adeno-associated virus (AAV) vector containing the Pdx1 and MafA genes, which are administered directly into the pancreatic duct. In humans, this can be done with a routine endoscopy procedure. GPX-002 is being developed using the same construct for the treatment of both T1D and T2D. In T1D, GPX-002&nbsp;is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but may be distinct enough from beta cells to evade the body&#8217;s immune system. In a similar approach, GPX-002 for T2D (formerly known as GPX-003) where autoimmunity is not a factor, it is believed to rejuvenate and replenish exhausted beta cells.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: center;"><img alt="diab.jpg" src="diab.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Preclinical data from a Non-Human Primate (NHP) study of GPX-002 in T1D showed statistically significant decreases in insulin requirements, increases in c-peptide levels and improvements in glucose tolerance in the treated animals compared to baseline. These groundbreaking results support the hypothesis that this disruptive gene therapy approach developed by UPitt researchers may be a promising treatment for T1D and T2D.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We finalized components of the diabetes construct to take forward for nonclinical studies and&nbsp;submitted a request to meet with the FDA to obtain their guidance on the nonclinical studies needed to file an Investigational New Drug (IND) application and initiate first-in-human studies. As a result of the FDA&#8217;s response, we will continue with our planned additional nonclinical studies before requesting regulatory guidance in 2024 for the IND-enabling studies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Advancing Our Programs in 2024</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We are excited as we look ahead to the second half of 2024 and beyond. We are a science-driven company, and we are committed as ever to advancing our gene therapy programs in both cancer and diabetes both in the lab and through our clinical programs. Most importantly, we have a talented and experienced team that is dedicated to our mission and focused on executing our strategy aimed at bringing safe and effective therapies to patients in need while building value for all of our stakeholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We plan to build and expand upon the promising data and regulatory progress made to date in order to continue our momentum and further the development of our potential life-changing gene therapies for patients with cancer and diabetes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: center;"><img alt="g01.jpg" src="g01.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Anticipated Milestones and Events</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Acclaim-1: Complete enrollment of 19 patients in each cohort of the Phase 2a expansion portion of the trial by end of 2024</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Acclaim-1: Report data from the interim analyses of the Phase 2a expansion portion of the trial, which is expected in early 2025</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Acclaim-2: Complete enrollment for the Phase 1 dose escalation portion of the trial in the second half of 2024</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Acclaim-3: Complete the Phase 1 dose escalation portion of the trial during the second half of 2024</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Acclaim-3: Start the Phase 2 expansion portion of the trial in the second half of 2024</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">GPX-002: Poised for guidance on IND-enabling studies in 2024</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Report and present clinical and preclinical data as it becomes available</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="genp.jpg" src="genp.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As always, we invite and encourage you to stay up-to-date with our latest developments by reviewing our latest <u>Investor Presentation</u>, inclusive of our most recent data. We also encourage you to sign up for <u>Email Alerts</u>, which will send our latest press releases straight to your inbox.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We look forward to achieving a number of important catalysts in the coming months that will further position Genprex as a leader in gene therapy. We sincerely thank you for your continued support and encouragement as we work toward transforming genetic medicine for patients afflicted with cancer and diabetes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Sincerely,</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Palatino Linotype&quot;, Courier, monospace; font-size: 16pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Ryan Confer</i></p>

<p style="font-family: &quot;Palatino Linotype&quot;, Courier, monospace; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Ryan Confer</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">President and Chief Executive Officer</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cautionary Language Concerning Forward-Looking Statements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Statements contained in this stockholder letter regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Genprex&#8217;s reports that it files from time to time with the Securities and Exchange Commission and which you should review, including those statements under &#8220;Item 1A &#8211; Risk Factors&#8221; in Genprex&#8217;s Annual Report on Form 10-K for the year ended December 31, 2023.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Because forward-looking statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: Genprex&#8217;s assumptions, expectations and beliefs, and Genprex&#8217;s plans, intentions and strategies, and its ability to execute the foregoing in accordance with the expected and/or desired results; Genprex&#8217;s ability to advance the clinical development, manufacturing and commercialization of its product candidates in accordance with projected timelines and specifications; the timing and success of Genprex&#8217;s clinical trials and regulatory approvals; the effect of Genprex&#8217;s product candidates, alone and in combination with other therapies, on cancer and diabetes; Genprex&#8217;s future growth and financial status, including Genprex&#8217;s ability to maintain compliance with the continued listing requirements of The Nasdaq Capital Market and to continue as a going concern and to obtain capital to meet its long-term liquidity needs on acceptable terms, or at all; Genprex&#8217;s commercial and strategic partnerships, including those with its third party vendors, suppliers and manufacturers and their ability to successfully perform and scale up the manufacture of its product candidates; Genprex&#8217;s intellectual property and licenses; and Genprex&#8217;s current expectations, estimates, forecasts and projections about the industry and markets in which it operates.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">These forward-looking statements should not be relied upon as predictions of future events and Genprex cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by Genprex or any other person that Genprex will achieve its objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Genprex disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events, except as required by law.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">3300 Bee Cave Road | Suite 650-227 | Austin, Texas 78746 | 1-877-774-GNPX | www.genprex.com</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gnpx-20240627.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/27/2024 3:44:48 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:gnpx="http://www.gnpx.com/20240627" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gnpx.com/20240627">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gnpx-20240627_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gnpx-20240627_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gnpx-20240627_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.gnpx.com/20240627/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="gnpx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>gnpx-20240627_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/27/2024 3:44:48 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.gnpx.com/20240627/role/statement-document-and-entity-information" xlink:href="gnpx-20240627.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.gnpx.com/20240627/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>gnpx-20240627_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/27/2024 3:44:48 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>gnpx-20240627_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/27/2024 3:44:48 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.gnpx.com/20240627/role/statement-document-and-entity-information" xlink:href="gnpx-20240627.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.gnpx.com/20240627/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>acclaim3.jpg
<TEXT>
begin 644 acclaim3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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DE%Q>W+![F<# 8CHH]AD_F37644W.ZLB8TTGS-W84445!J?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>aclaim1.jpg
<TEXT>
begin 644 aclaim1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MZ/\ $TZ]X/M(I+1+@7,:^<J8S]^/!/3J/H:]%\=> ['QWHT<5UFUO81NM[@
M$QD]5/JM=915.I)V?8R5&*371GS=_P *X^)?AB9X=$:X,+'[]A>A%;WP2#^E
M=#X&^&?C:'Q;;:_KNHM9/"V7,DWGRRKW0\D8(XY/X5[A15NM)HA8:"=[LY'Q
M_P##^Q\=:8B2O]FOK<'[/<A<[<]58=U/Z5XX/AW\3?#,KV^BM<^2Q^_87H5&
M]\%@?S%?2-%3&I**L5.A&;OLSQ/P#\-/&=IXMM_$&O:B;-XS^\$DWGRS+W0\
MD8/N?PJ?XM_#OQ'XK\6P7VBVD<UNEHL19IE3Y@S'H3[BO9:*?M9<W,'L(<G(
M9\^DV^I>'3I6IQ"2&:W$,R9]L=?7WKP36?@UXM\/:L;GPK(UY"K9AF@F$4R#
MT()'/T-?1=%3&;CL54HQJ;GSY8_"GQSXIN%D\87L\,$2DJ+FY\Z0G' 49(&?
M4_K6]\)/AYXB\)^+KB^UNTCAMWLVB5EF5_F+H0, ^@->RT53JR:L1'#PBU+J
M>*_$;X<>)/$/Q%.K:59QRVFV$;VF13\H&>"<UV'Q:\,:IXK\(PV.BPK-<)=K
M*5:0)\H5AU/U%=U12]H]/(KV,?>\SC_A=X?U'PSX'ATW6(EAN5FD<JKAN">.
M16=\7_">K>+O#]C:Z' LTL-UYCAI%3"[".Y]37H-%+F?-S%.FG#DZ'*_#;0[
M[PYX"L=,U6)8KJ$R%T5PP&78CD<="*P?C%X/UGQ?I^EQ:%;K.]O+(T@:14P"
M!CJ?:O2**%)J7,#IIPY.AS_@32KO0_ VEZ;J,8CNK>(K(H8-@[B>HX[UT%%%
M2W=W+2LK(****0S-\1V<VH>%]4LK50T]Q9RQ1J3C+,A Y^IKF_A1X;U+PMX-
D;3]:A6&X-T\FU7#_ "D+CD?0UVU%5S.UB.5.7,%%%%26?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>aclaim2.jpg
<TEXT>
begin 644 aclaim2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MABQ'#'L.!7;:-K-CK^E0ZAI=PD]O,H(*G[I]".Q'I4ZWUH]^]DES$UTB"1H
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11IJ+O=_>%%%%0:A1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>diab.jpg
<TEXT>
begin 644 diab.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M?\:T8)?.MXY=I7>H;:>V1TIS-M4MZ#-1>GV?W_\  *M/NON_X)F?\+#\'_\
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M3[K[O^"9?_"P_!__ $,NF?\ @2O^-'_"P_!__0RZ9_X$K_C6I11>GV?W_P#
M"T^Z^[_@F7_PL/P?_P!#+IG_ ($K_C1_PL/P?_T,NF?^!*_XUJ447I]G]_\
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MX;3&:1EFE" MN4@?3BNA\5_\CMX._P"OJZ_])GK?K3G<.62[?JS/E4G)/O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 #QUQ7=8HQ1S:!RZA52<YE-6ZI.=SD^]24-HHHH **** "BBB@ HHHH PM
M_P"2C>)?^O.P_G/765R>@?\ )1O$O_7G8?SGKK*TJ?%\E^2(AM\W^9R/BO\
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M]?[X_J.Q^M>@YKYV<)4Y.,CV824X\R%HHHJ"PHHHH ***:\BQH6<A549))P
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M^<]=97)Z!_R4;Q+_ ->=A_.>NLK2I\7R7Y(B&WS?YG(^*_\ D=O!W_7U=?\
MI,];]8'BO_D=O!W_ %]77_I,];].?PQ]/U8H?%+U_1!11161H%%%% !1110
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M,**** "BBB@ HHHH </NM]*;3A]UOI3: "BBB@ HHHH **** "BBB@ HHHH
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MM!4'&2U..=.JZO,GH>CT445YYV!1110 4444 86@?\E&\2_]>=A_.>NLKD]
M_P"2C>)?^O.P_G/765I4^+Y+\D1#;YO\SD?%?_([>#O^OJZ_])GK?K \5_\
M([>#O^OJZ_\ 29ZWZ<_ACZ?JQ0^*7K^B"L"^\;^']-U&XLK[4!#-;,JS9ADV
M1%@&&Y]NT<$'D]ZWZ\[NVU.RU[Q;:1>&[_41J[QBVE54$!'V=$.YF88 (.>#
M412>Y4FUL=W%J-M/>M:12%Y5B68X4[2C$@$-C!Z'@&F7&K65IJEGI]Q<!+J^
MW_9XMIS)L&YN>G ]:\\N])\3:-IOV&W2]OH;;2+&W/V>:10761A*8PK*2P7;
MP"I(P,UBOH^OS2:'/JNEZW=6MC=WVY()&2X6W9%V ,9"WJ,;R< C)J^1=R'-
M]CVGO445W;S3S0PSQR2V[!9D5P6C) 8!AV)!!^AKRS4]-\:?V+H:W4NJ,5LY
M%;[&3+-#.7S&S[98PQ"8&6+#(;(YS4LV@>(K*?Q/_9JZE_:-_%;SQ79G;9*
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M7?)&)'<E!NYX8#G'-=+X:L]0N_&6I^(KK2WTF"ZMHK>."9E,LQ4L?,<*2!U
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MA+P\WAS39X)/),MQ<-.YA:5@254<F1V8GY>N1]*EJ-M!IROJ;U%%%06%%%%
M!1110!A>(?$<NBWVF6=I8"\GU!Y%0-<"$+L7<<D@]JK6'CO29M/^T:K-'IDH
MNI+0Q2RAMTB8W!&'##D=*G\0>%K?Q%K&CW-^D$]KI[RM);SQ!UEWIM'!XX//
M-.G\,0?VSH=U81P6EMI1G(MXH@H/F)MXQP,'FK]VQ'O7'-XT\-HTZMK5G_H_
M^M/FC"?,%//3AB ?0D9JS=^(M(L?M'VN_AC^SE%ERWW6<94?4@9 KBM(^$L%
MBES97]S%>6,D,\,;'S1*JRGT+F,$>H7G /%7(/ &HVO@]-,AUIC?/>+<W5S\
MZ?:%5=@0E&# ;53H>J^].T.X7EV-QO&&F+J<,/GP_8IM/?4/MYE C"*ZKU_X
M%U]L4]O&OAQ+5+EM8M1#(YC5B^,L "5QUS@@X]Q7*2?"J6Y\/PZ7<:JJB/3)
M+(RI$2=S7"S*V">@VX(SGGK4VG?#>>UU72K^:ZMA)97AN91'YS&8>4$'S2.Q
MR,9].@]Z=H=Q7GV.IG\6Z#;65K=SZK:K!> M;OYG$@'4CV'<]JE7Q'HS:L-+
M74K8WI.!#Y@W$XSCZXYQUQ7,V'@?5-';3[C2M1L_M5K!<6TGVFW9XV26;S00
M P((X'7!HA^'C0^,6U=KBWF@:_-^JR>=OC<CD*!($Z]RI.#CFIY8]QWEV.YH
MHHJ"PHHHH **** ..T;Q]_:H-Q+96]I8KYIDF>_1I$6,L"QC R!E?RYK7E\8
M>'H5E:35[4)%LWOYF54N,H,],D<BL'1/"&M:%;&"V.@N5$VRY:R?SLN6(W-N
MY +8([@8]ZR)/ >K^']$LM+T>XAO($U:VNHF:WPT3!LNS@$!DSSV('&>F-.6
M+9G>5CMO^$O\/_V>M]_:UO\ 9GE,*ONY+@9*XZYQSC%1S^-O#=M+''/K5FC2
M(DB R#YE;[K?0^O2N8O?AM?7\YU&YU&W.IM?273K&)8H2&C6/:"CAP<(#G/K
MQ2#X7R+:ZK#%>6\0O]+CL5"1OB-E8L6^9B2,GH3FBT.X7GV-WQ+X]TGP[(MN
M98[J^\^*%K5)0&3>0 3QV!SCKBHH_B)I*Z];:/>_NKNYGFBC,;B1%\MBHW'C
M!8CI@X.<FLK5?AS?W<UY#9:G;1V%YJD>J.LT!:59!C<H;.-ORY'&1TJU#X"N
M[76[#5+:_A,MI>WDS1R1DJ\=R^2 0>&4=#TS3M"P7G<Z+_A*=#-E%=C4[?[/
M-#)/')NX:.,X=OH,C-5_^$W\,^2DO]M6ACD)"L'R#C&3[ 9&3TYKDH/ACJB:
M1'I<^KVCVUM87EE;%;=@^)R#N8[L'&.@Q5O5OAM+>C36@NX=UMI::;-'*9E2
M15_B'ENI[GY3D&E:'<+R['71>(]'GU=M+@U&WDO5)!A1\D$#)'IG'..M:5<5
MI/@:ZTKQD-6MKR"VM26,T%L)5^T IM7>K.5R.#N R<5VM3*W0J-^H4445)04
M444 <QK/C>VT>;5EEM7ECTR.#S'5P-\TQPD0!]L$DG S5SPWX@DU^QGN#:PQ
M>6VU6@O8[B.3CLR'\,$"N?U;PC/K&L>);&53%#J7V2\MKIH]\:R1 *489&?]
M6I(]&J]X=\*ZIHFK7NH/>6)?4[H37D,-NR1JBQE5$?S<'."2<Y]*TM'E\R+R
MOJ03^/;RPO-0M]3T!H?[/L3>SM%>++M'(53P,%B#^ )J73_B%9WMY!920+;7
M1NIK:Y$EPNR'R^"X?'S!F*J!P22?[IK4T/P]_9W]IS:C)'=W.J7+2W#;/EV8
MVI'@]0$ '/OZURM[\+/M*74T%S:175S),I4V^888'C:-$101@J&W9[L31[@O
M>1U_B/Q%;>'-.CN)HI)Y;B9+>VMXL;YI7^ZHSP/J:@3Q!=6FD7]_XBTIM,CL
MH_-+"X259!@GY2.<\8P0.HQFH]>\*+K&A6-G'=O#=:;+%<6ETR[L2Q_=+#C<
M#SD<=:HZIX8UWQ)I?]GZ_JMHEM)<1O,MA \;>6F3M#,Q.2VTY[8]Z2M8?O$E
MMX_LO^$.NM>U6UGT\V3^5<V;C=+&YQM7'&2P92/KS1+XPU"RTW4+S5] :T6S
MM'N@HO8Y"VT9V,!RK8]B/>LZX^%\,T6K6AU:]EL]5AC\UKF4RS)/$V4D#'MC
M@@]<"H+[X>ZKJ]]>7NIWVFI<SZ9-8&2ULV0REP )')8Y(QTJK0%[Y<F^(<]G
M%<?;-%Q,EA)?Q1P7B2AXX]N\$@94X;(R.<$5V%A>Q:EIMM?6IW0W,2S1D]U8
M9'Z&N'UCP:VA6&J7OAFTB)NM(:SFL8(0OG2XPDBXZ?>;/J/I76^'=-?1_#&F
M:;*VZ2TM(H7(Z$JH!_45,N6V@X\W4TJ***@L**** ,27Q(5UC4[&VT^>[_LV
MWCDE\@@L\CY*QJIQD[1G.<#(JO9>)[S5?"=CK6EZ2)?M0+/#+=+'Y2@D9+$8
M/2H+>PU.S\9>(I+.)0-1@@GM[F52T2NJ^6R-@@YPH/'K6?;^"M:_X5^?"MUJ
MEHL#%8C/;PL'\G<6D')(W'. >@&>M:6B1[QN:!XCGU[PI_;,6ER(S"0PVPE4
MF8*2 58X&&QP3CUK*_X6!)%)J-K?:.T%_8O;(85NE=&,[[$!D ^3!Y((Z>M;
MDUAJ5K!;VN@SVEK:06KPJDL3,58+B,@@C@'J._M6/X3\(WFBZ;=V&L?V9J$5
MT3)/)Y#%[F4G):3>2"/8#BCW0]X71OB#9ZQ>6EJ(H[=Y%D^T&2Y4"%UD,:HI
M_C+%6( QP,]ZUO$&O_V(EG%#:/?7M]-Y%M;1L%WMM+$ECPH"@DFN1D^%\[P,
M4NK&.XO(YHKPK;'8@=T(,(!&TJL:J,UU?B/0I]6;3[O3KI+74--N#/;R2Q[T
M;*E&1@"#@JQZ&A\M]!+FMJ5[SQ5-H_ANXU/7]*DLYHY!%#;),LIN'; 0(1ZD
MXY (P:1_&=L/"=GK,5K-++>RI;PV2D>89V8J8R3P,,&!/^R:H:GX.U7Q.]B/
M$VK1K#:2M.J:6CP,), )ABS'Y?G.>OS>U1Q?#V6TTZYL[+59-J:C'J=C+<@R
MO%.,;M_(WJQSZ'YC1[O4?O="S?>,[[2M&N+S4]$6*6*:&%(H[Y'5S(VW[P'R
MX/7(IG_"P!!!JOV_3&BGTN.*:=(;A94\IVP6# =0 Q*D \5G77PYN]3>_EOY
M=*A>]>U,D5G:%(W$4K2,6R3N9MQ!)]JDU?P;<:9H?B2S\/0PFSUI46.SCCVF
M"5\1NP/39@[B.V#3M 7O'? AE!4Y!Y!HID,8A@2-3D(H4$^PI]9&AA:!_P E
M&\2_]>=A_.>NLKD] _Y*-XE_Z\[#^<]=96E3XODOR1$-OF_S.1\5_P#([>#O
M^OJZ_P#29ZWZP/%?_([>#O\ KZNO_29ZWZ<_ACZ?JQ0^*7K^B"BBL;4M.GN=
M8@FC7='A [,!A5!)8#YOX@<$;3VK.*394FUL;.:*Y9=$U2!XY;1E@><.LR(P
M"PAR/NCNRA5Y[G/K4LFFZC#:6:1))*5TQ[1P)1E9"$VL23ST/(R:T<%T9/.^
MQTE%8]Q%<C6(;V*SEF"1E65F3Y0-^-GS#!;(ZCD$9(Q3-3;7#J:_V<F+;RF#
M$E""VUB",\@[MH]*2A=VN/FLMC;HKF%MM=CMKBW$;O%.K;"[1[D)DD+;L'J5
M9.GOTJS9P:O;WD*.9GM_,/F!FCVA=HQ@_>X((QCD]Z.33<7M/(WLT5R]W87M
MVK?9X)?M*SR[IB^WY=S;0&W9'RE>BG/ R.U8:%JZVS&&0QL68%,!?D('R@!R
M%W'@\GIG*]*KV:[B=1]CL:*CMS*UK$;D!9B@\P+T#8YQ^-25B:A1110 45C:
MA:W+ZR)XK<RQ^0%5E5248%NFYAM/(YP:SH[GQ&^I2VI8>?%;1R$ )Y.YGE!R
M?O8PJXQSTS6BA=;F;G;='545SJPZ_):21SRS;WA<1LJPJ5?;QNY/&>A'XTH&
MO^<^YIO*X 4)%NVY'0DXW8SG(QUQVI^S\P]IY'0T5@FUU:"TT\6[2!HK013*
MC)PV4S][@G:'P>F>O&:G>+59;*! [*VZ3S<[-Q7YM@/;)^7./>IY?,?/Y&O1
M7-2)XD =('=1O&URD1P,'@+D< [<DG)]N:M7\6L+J#/9/(86V;PACR  ^0@;
MH=VS.>V<<T_9Z[BY_(VZ*Q+RWU5[NRGB2&22.'#!S^[20XRW7/K@@$_0&J2:
M5J8>/SHO,F%VLIG\P,-N5+8)*[<X;@*>./>A036X.;3V.HS17-Z+IFK6]U9&
M_?\ <VD#0J ^2V0#N;U(X7_@)/\ %4-LVMV-O8V8;#R(D 6<H60A<O(-O55"
M\9ZEN>U/V:O9,2J/JCJJ***R-0HHK,U*TEN;ZQDAB&89 6EP!M7N,YS^77H:
M:5V)NR-.BN<;1KR)K585W1PR2[0S!MFZ7<&);G.WN.0:;I>D:G827:.8WCE@
M98S@<8)V+CG'WB<=.?:KY%:]R.9WV.EHKGWM-=1%,5P<' =$V#:H*<)Q@'&_
MK[=*?):ZT#"\5W(,S$R*0C80'Y1V&,9SSGIBCD7<.=]C=HKFXH?$7F1L[L1Y
MRLR$H!CC=D\G P<8'.>@SQ8BMM9.A-'<3"2^\P,K,B@#&,XQD8SG!Z\T."[@
MIOL;E&:P=0;4+#2Y/]*=G:X01RN4&%(&[)P .0W7U [U6L+?5FACE265DG\M
M]S!%W<*'+CGJ!P%Z'-'L]+W#GUM8Z>@'/2N9M;7Q!;P6L*LRQQM$&WLA("[=
MXX ^4C..IX]^-?0[26PT*SM;@ 2Q1*K '/(%*45'J.,F^A?HHHJ"PHHHH **
MR_$5C<:CI)@M!F7S$< OM4X.<-ZCVXJC_9%R5NXTM+<^<2?,N(T;#EOO#N5
M)(#<\ >M6HIJ]R')IVL=%17/Z3H\^G:T[H@6V6)HU8D9883;TY.-AZ],\=:C
MBA\111H\UR7(?=,-J 8XR$ZYYY&<<;AU(P^1=Q<[ZHZ2BN3L%\276FV,QN9$
M$D:/)N6-G+%5.>P"YSQUJU+::V522.>83A'1OF0KDLARHXXP& SR#C.!S3]F
MNX<[['1=**P;2TU;[?9O?2/+'"Q;<P10 491D#)W9;L<8HBT^]%\LCQMY444
M\/RR#,GF2JP8>F%!Z^O%+D5]PYGV-ZBLS1;>>SMS!):I#&&RA554D8 ^8*2-
MQYY'IVK3J&K.Q<7=7"BBBD,**** "BJ^H0O<:;<0Q,ZO)&RJ8VVL"1V/8^]<
MR^DZG)I5K;I:R17$=H5,RW'<A@$RS;AUR3SSM[#-7&*>MR)2L]CKLT5S=SI]
MU)HDEK%92J^7:#+*PB#%L#[XP1QR,XR,=*=96&IP:A=S")49DN-C-C:[-)E,
MX8[N/4+CISV?(K;BYW?8Z*BN99O$<%JLCR95 S3&1(PX '&W:2#R"3G'R].:
ME0^('6W:-B$+DMYJQEB/DP&P0 /]9RO(&VG[/S#VGD=#17-RQZ_MWV[W.]HT
M5Q+Y)QAOGP!QD@\?0Y[5+:VVK2:S:S7Q=HXHW#-A%7)1<$ $G.0V>2/2ER66
MX*=WL;]'6L&*UOGLC!/#=1_Z$+4O%*F\M@Y=3NX[8)YR15W18IK>Q$$]MY&S
ME2,#<"3U 8X/&3SCGZ@*4;=1J3;V-&BBBH+,+0/^2C>)?^O.P_G/765R>@?\
ME&\2_P#7G8?SGKK*TJ?%\E^2(AM\W^9R/BO_ )';P=_U]77_ *3/6_6!XK_Y
M';P=_P!?5U_Z3/6_3G\,?3]6*'Q2]?T04445D:&;<ZY;VER\,D<Q*N(PRJ,,
MY (4<YS@CKQ[U$_B.VC61I(9U2(?O20OR'++@_-ZH1QD=.:N#2[/[1//)!'+
M).?G,B!N-H7;R.GR]*8FCV$=T9UM8MVP( 8QA ,]..,[CFM%R6,_?N59?$5O
M'=21!'<1%T<# 8N!&<+D@'B3/7L:(?$<,P#+!+L<?N^F9,F,+@9XR91U(JX=
M,TV. JUE:K$N6(,2[1TR>F.P_*D%OI9M))A#:F H=[A%V[0!U]@%7\AZ4_<[
M![_<J-XD@\B26."9DC!)9@ ,A!(1USG;GMC/&:GEUA+?47MYXV6,(&$N0%SM
M=B#D\<(?;W%3S:?:2VQA:%%BX)"@+VQV_P!GCZ<5*UO!,"9(HY-PY+(#G@C^
M1(_&E[O8?O\ <R?^$KL!&6=+A",D*R#+8+@XYP<%&'7NOJ*U+*\2^M%N(TDC
M#$C;*FU@02#Q^%(MA9I&L:VD 159541# 5OO#IT..?6I888K>(1P1K&B]%1<
M ?A2DX]!KFOJ/HHHJ"@HHHH *Q+C7YK=KC-DK+$Y =9OE8*C,PSM^\ N,8QD
M]>#C;JHNE:>N[%C; ,P9AY*\MSR>.O)_.JC;J3)-[%"779X[R2U6T0R* REY
M6167:YSDKU^3MD<]>#4MSXAM+0Q^:)#OA\["X)4;68 C.1D*<<5<;3+%PX:R
MMV$C;GS$IW'GD\=>3^9I9+"SFG\Z6U@>7;LWM&"<<\9].3^9]:J\.Q-I]RC)
MKRB80+;3"99HXY5?;^ZW,H!)!.<ALC&??%-O]:N;*ZEC6R26.-%;>LI)RSA5
M&T)G)Y.!D\>XK2>RM9)UF>VA:56W!VC!(/'/Z#\J62U@E1UEAC=9""X9 0Y&
M,$COT'Y4)QOL'+-]3$G\2W$,$<BZ=YIF@6:)$E.6)9!MR5"Y^?L3TYQFIX_$
M*7%I>W%K"7BM]AC;/^M!ZX';!R/PK033K*)]\5I C<?,L8!XP1S[$ _@*?\
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MCOCM4]%%9&BT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI:*S=$N9KNUFEN'+DS$*WEM&"N!C"MR.]:58-6=C9.ZN%%%%(84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8
M6@?\E&\2_P#7G8?SGKK*Y/0/^2C>)?\ KSL/YSUUE:5/B^2_)$0V^;_,Y'Q7
M_P CMX._Z^KK_P!)GK?K \5_\CMX._Z^KK_TF>M^G/X8^GZL4/BEZ_H@HHHK
M(T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@! H!) Y/7WI:**   #.!C)R?>BBB@"G_:<?F3YAF\J!BKSA05
MW<9  .X]?3'6J\OB'3XX'FC=Y55-Q*(<?ZLR8R>,[1G'7FG76@VEV\K2O,!*
MZR,BR?*'&,,!TS\HH_L"Q_L_['MD\G&/]8<_ZKRNO7[M:>X9OGZ"+KU@;HP-
M*R$;06DC90&8D!3D?*<COC.1BG)KNFR1HZ7(9';8&\ML9XX)QQG(QGKD5$/#
M5AYPED\Z5MX=_,E)$C*<J6'?!Z4T>%]/'E<SD1!0H,G93E0?7!_^OFG^[\Q?
MO#0M+V"^1GMG+@8SN0KU (."!VJQ4-O:16I8Q C<%4Y.>%&!^E35F[7T-5>V
MH4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,+0/\ DHWB7_KSL/YSUUE<GH'_ "4;Q+_U
MYV'\YZZRM*GQ?)?DB(;?-_F<CXRBNTU_PUJ-M875[#97$[3K;1[V4- R XSZ
MD4__ (2:3_H7M<_\ _\ [*NKHHYTTDUL'*TVT]SE/^$FD_Z%[7/_  #_ /LJ
M/^$FD_Z%[7/_  #_ /LJZNBES1[!:7<Y3_A)I/\ H7M<_P# /_[*C_A)I/\
MH7M<_P# /_[*NKHHYH]@M+N<I_PDTG_0O:Y_X!__ &5'_"32?]"]KG_@'_\
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M)_T+VN?^ ?\ ]E75T4<T>P6EW.4_X2:3_H7M<_\  /\ ^RH_X2:3_H7M<_\
M /\ ^RKJZ*.:/8+2[G*?\)-)_P!"]KG_ (!__94?\)-)_P!"]KG_ (!__95U
M=%'-'L%I=SE/^$FD_P"A>US_ , __LJ/^$FD_P"A>US_ , __LJZNBCFCV"T
MNYRG_"32?]"]KG_@'_\ 94?\)-)_T+VN?^ ?_P!E75T4<T>P6EW.4_X2:3_H
M7M<_\ __ +*C_A)I/^A>US_P#_\ LJZNBCFCV"TNYRG_  DTG_0O:Y_X!_\
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77*>=NP,GIN'YUUU%%*4N9W'%<JL?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g01.jpg
<TEXT>
begin 644 g01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MKG_@XN?_ (NMC^W=(_Z"EE_X$)_C1_;ND?\ 04LO_ A/\:/:5.[#V=/L8_\
MP@.F?]!#7/\ P<7/_P 71_P@.F?]!#7/_!Q<_P#Q=;']NZ1_T%++_P "$_QH
M_MW2/^@I9?\ @0G^-'M*G=A[.GV,?_A =,_Z"&N?^#BY_P#BZ/\ A =,_P"@
MAKG_ (.+G_XNMC^W=(_Z"EE_X$)_C1_;ND?]!2R_\"$_QH]I4[L/9T^QC_\
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M@.F?]!#7/_!Q<_\ Q='_  @.F?\ 00US_P '%S_\76Q_;ND?]!2R_P# A/\
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MS_\ %UL?V[I'_04LO_ A/\:/[=TG_H*67_@0G^-'M*G=A[.GV,?_ (0'3/\
MH(:Y_P"#BY_^+H_X0'3/^@AKG_@XN?\ XNMC^W=(_P"@I9?^!"?XT?V[I'_0
M4LO_  (3_&CVE3NP]G3[&/\ \(#IG_00US_P<7/_ ,71_P (#IG_ $$-<_\
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M+_P(3_&CVE3NP]G3[&/_ ,(#IG_00US_ ,'%S_\ %T?\(#IG_00US_P<7/\
M\76Q_;ND?]!2R_\  A/\:/[=TC_H*67_ ($)_C1[2IW8>SI]C'_X0'3/^@AK
MG_@XN?\ XNC_ (0'3/\ H(:Y_P"#BY_^+K8_MW2/^@I9?^!"?XT?V[I'_04L
MO_ A/\:/:5.[#V=/L8__  @.F?\ 00US_P '%S_\71_P@.F?]!#7/_!Q<_\
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MC^W=(_Z"EE_X$)_C1_;ND?\ 04LO_ A/\:/:5.[#V=/L8_\ P@.F?]!#7/\
MP<7/_P 71_P@.F?]!#7/_!Q<_P#Q=;']NZ2.NJ67_@0G^-']NZ1_T%++_P "
M$_QH]I4[L/9T^QC_ /" Z9_T$-<_\'%S_P#%T?\ " Z9_P!!#7/_  <7/_Q=
M;']NZ1_T%++_ ,"$_P :/[=TC_H*67_@0G^-'M*G=A[.GV,?_A =,_Z"&N?^
M#BY_^+H_X0'3/^@AKG_@XN?_ (NMC^W=(_Z"EE_X$)_C1_;ND?\ 04LO_ A/
M\:/:5.[#V=/L8_\ P@.F?]!#7/\ P<7/_P 71_P@.F?]!#7/_!Q<_P#Q=;']
MNZ1_T%++_P "$_QH_MW2/^@I9?\ @0G^-'M*G=A[.GV,?_A =,_Z"&N?^#BY
M_P#BZ/\ A =,_P"@AKG_ (.+G_XNMC^W=)'75++_ ,"$_P :/[=TC_H*67_@
M0G^-'M*G=A[.GV,?_A =,_Z"&N?^#BY_^+H_X0'3/^@AKG_@XN?_ (NMC^W=
M(_Z"EE_X$)_C1_;ND?\ 04LO_ A/\:/:5.[#V=/L8_\ P@.F?]!#7/\ P<7/
M_P 71_P@.F?]!#7/_!Q<_P#Q=;']NZ1_T%++_P "$_QH_MW2/^@I9?\ @0G^
M-'M*G=A[.GV,?_A =,_Z"&N?^#BY_P#BZ/\ A =,_P"@AKG_ (.+G_XNMC^W
M=(_Z"EE_X$)_C0-=TDG U2RS_P!?"?XT>TJ=V'LZ?8Q_^$!TS_H(:Y_X.+G_
M .+H_P"$!TS_ *"&N?\ @XN?_BZV/[=TC_H*67_@0G^-']NZ1_T%++_P(3_&
MCVE3NP]G3[&/_P (#IG_ $$-<_\ !Q<__%T?\(#IG_00US_P<7/_ ,76Q_;N
MD?\ 04LO_ A/\:/[=TC_ *"EE_X$)_C1[2IW8>SI]C'_ .$!TS_H(:Y_X.+G
M_P"+H_X0'3/^@AKG_@XN?_BZV/[=TC_H*67_ ($)_C1_;ND?]!2R_P# A/\
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M8W8L _S\%FD)"-AB6/!)K.C_ +7UO0=6N;W6[B1--CC=[2XFD=G5I53@'Y0
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MY_\  +_[.O9H]:TOYLZG:?>.,W"?XT[^V]*_Z"=G_P"!"_XT>TJA[.F>+_\
M#-2_]#.?_ +_ .SH_P"&:E_Z&<_^ 7_V=>T?VWI7_03L_P#P(7_&C^V]*_Z"
M=G_X$+_C1[2J'LZ9XO\ \,U+_P!#.?\ P"_^SH_X9J7_ *&<_P#@%_\ 9U[4
M-7TTC(U"U(]IU_QI?[6T[_H(6O\ W^7_ !I>TJA[.!XI_P ,U+_T,Y_\ O\
M[.C_ (9J7_H9S_X!?_9U[7_:VG?]!"U_[_+_ (T?VMIW_00M?^_R_P"-'M*H
M>S@>*M^S@L[&7_A)L;N>+//_ +/2?\,U+_T,Y_\  +_[.O:(M6T_RUW7]MG'
M>9<_SI_]K:=_T$+7_O\ +_C1[2H'LX'BG_#-2_\ 0SG_ , O_LZ/^&:E_P"A
MG/\ X!?_ &=>U_VMIW_00M?^_P O^-']K:=_T$+7_O\ +_C1[2J'LX'BG_#-
M2_\ 0SG_ , O_LZ/^&:E_P"AG/\ X!?_ &=>UC5=.)P+^U)]IE_QIW]I6/\
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M . 7_P!G7NU%'MI]P]E#L>$_\,U+_P!#.?\ P"_^SH_X9J7_ *&<_P#@%_\
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M:9SG,CV[0$C)QE&Y!QCZ]0 #BK=% !45Q_JA_P!=$_\ 0A4M17'^J'_71/\
MT(4 <S\09+Z?0H]&TNQN+R759/(E$!"E(.LIW-A02H*C)'+5RJGQ#HVG:YI.
MF:+J&F0SO'=V20[)'BB+*MPD;(2H;&64=>3CD5ZK15J5E8SE3N[W/,;I;5-(
MMHM!G\0-H;7H_M64BY,RQ^6<;-XW[=^-^SGK4&H6]\M_#<>$(]3E\O0+N.VF
MNTE,F[SDP 9!G. 2@/H*[W5?$MII6JV>FO#<7%Y>DB&*$+R<$\EF '"N>O\
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MW\L*\49;86=-^S/(''UQ70T5%];FMER\I$W_ !^1_P#7-OYK4M1-_P ?D?\
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M4KA3YF0,'I4#_#CXF>9E[*]+C<=W]H1G[P ;GS.X50?4 >E;>U7\Z_ CD?\
M*S%/@;4&^UM;R+-#;6_GK*J-MF^]A4.,-D1N01Q\N,YXJE/X?,FJ"ST2Z75?
M]&\]GA7 7 RR_4=/QKJ&^'OQ-:2-VM+\O$P:-CJ"90CN#OX-4E^$OCM6)70Y
M 2""1<Q=#P?XZ:JQZS0G!](LQ=.\,W&J:9-<6DF^YCN4M1:!#N9W5V&#TZ1M
MG\*=-X.URVE>.XM(XG1BKJ]S$I3 D8YRW Q$YR>#CW&=^V^&7Q%LU*VFF74
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M=P.TXVG!Z=C0 ^BBB@ HHHH **** "H+_P#Y!US_ -<F_D:GJ"__ .0=<_\
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MC_GK'_W[/_Q5&VX_YZQ_]^S_ /%5+10!%MN/^>L?_?L__%4;;C_GK'_W[/\
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M6OM$M=4;.I6UG=C9Y96>WWJ5W!L%2<'E0>>E)+H5E-&8YK'3Y$(92KV:D$,
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MK:=%;M/+?6Z1*65F:4  J,L#[@ DCM0!/MN/^>L?_?L__%4;;C_GK'_W[/\
M\55";Q+I,'V0O=Y2\3S()4C=XW7&2V\ J !R23P.3Q5H:G8,I9;ZV*J5!(F7
M +?='7OV]: )=MQ_SUC_ ._9_P#BJ-MQ_P ]8_\ OV?_ (JF65_:ZC;)/93I
M-&Z*X*GLRAE)'49!!Y]:L4 4T6?^T)OWD>?*3_EF?5_]JI]MQ_SUC_[]G_XJ
MJLU]:6>I2"[NH8"T*;1+(%SR_3-+_;>E?]!.S_\  A?\:JS%=%G;<?\ /6/_
M +]G_P"*HVW'_/6/_OV?_BJK?VWI7_03L_\ P(7_ !H_MO2O^@G9_P#@0O\
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MG_XJJ4GB32$ANY$O5N!9QK).MJK3NBL,JVU 201SP#QS3M/\1:5J=M#-:WB
M3;=B3*89#N^[\C@,,@9&1R.1Q2 M[+O_ )[P_P#?D_\ Q5&R[_Y[P_\ ?D__
M !510ZM87-Z]I!=Q23H%+*K9^\7 &>A/[I^!R-IS5:X\3Z1::M_9US=^5.#@
ML\3B)6V%]IEQL#; 6VELXYQB@"]LN_\ GO#_ -^3_P#%4;+O_GO#_P!^3_\
M%55N/$.D6RHTVI6P5W5 5D# %LXSCH#@\GBIWU33XY&22^ME=&",K3*"K$9
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ML-EW_P ]X?\ OR?_ (JC9=_\]X?^_)_^*KC_ /A<7@3_ *#O_DG/_P#$4?\
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M_P ]X?\ OR?_ (JC9=_\]X?^_)_^*KC_ /A<7@3_ *#O_DG/_P#$4?\ "XO
MG_0=_P#).?\ ^(H]C5_E?W![2G_,OO.MB2Z\I<308Q_SP(_]FI^R[_Y[P_\
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M2Z_L^XS-"1Y39Q"?0_[57J@O_P#D'7/_ %R;^1IB)ZY3QO\ \?WA3_L/1?\
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MS0A)%6)"\.0BX+R,P^[\H0_,<BM"./QY/87E\E\;:7[7,+6SG@BDS$;@K&6
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M_P"0=<_]<F_D:GJ"_P#^0=<_]<F_D: )ZY3QO_Q_>%/^P]%_Z)FKJZY3QO\
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M;:.GKV^M #/+NO\ GX3_ +]?_7H\NZ_Y^$_[]?\ UZGHH @\NZ_Y^$_[]?\
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M^R__ !NC_AG[Q/\ ]!'2?^_LO_QNCZU1_F#V%3L>5T5ZI_PS]XG_ .@CI/\
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M Q?^_P#_ /8T >@+=W8S^^[]XP*=]LN_^>P_[X%>>CXCN.FEJ.<_Z\_X4?\
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M7VR[_P">P_[X%'VR[_Y[#_O@5Y[_ ,+(D_Z!B_\ ?_\ ^QH_X61)_P! Q?\
MO_\ _8T >A?;+O\ Y[#_ +X%'VR[_P">P_[X%>>_\+(D_P"@8O\ W_\ _L:/
M^%D2?] Q?^__ /\ 8T >A?;+O_GL/^^!1]LN_P#GL/\ O@5Y[_PLB3_H&+_W
M_P#_ +&C_A9$G_0,7_O_ /\ V- 'H*WEV$ \[MWC -+]LN_^>P_[X%5H'\RV
MC<#:&0' /3BGT 3?;+O_ )[#_O@4?;+O_GL/^^!4-% $WVR[_P">P_[X%'VR
M[_Y[#_O@5#10!-]LN_\ GL/^^!39+N[,;#SNH/W8P3^ J.FR8\IMVW&TYW'
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M_LX7&WS66T*.B1Q/LBV.X8@O'][(7)SNXSC%06GCA+J$7#33V021I1!/$DS
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MN?\ "MX_^@FW_?C_ .RH_P"%;Q_]!-O^_'_V5 '!T5WG_"MX_P#H)M_WX_\
MLJ/^%;Q_]!-O^_'_ -E0!P=%=V/AQ&2?^)HW!_YX_P#UZ7_A6\?_ $$V_P"_
M'_V5 '!T5WG_  K>/_H)M_WX_P#LJ/\ A6\?_03;_OQ_]E0!P=%=Y_PK>/\
MZ";?]^/_ +*C_A6\?_03;_OQ_P#94 <'17>?\*WC_P"@FW_?C_[*C_A6\?\
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M]_R3S7?^O&7_ -!-=$OXL?E^2,8_PW\_S9\BT445]&>.%%%% !1110 4444
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M )+_ (4>6W_/9_R7_"GT4 001M]GC_?/]P=E]/I4GEM_SV?\E_PH@_X]HO\
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MA5ZB@"C_ &3%_P ]IOS'^%']DQ?\]IOS'^%7J* */]DQ?\]IOS'^%']DQ?\
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MH_LF+_GM-^8_PJ]10!1_LF+_ )[3?F/\*@O=+B6PN&\V8XB8X)'I]*U:@O\
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M:^NM3G65)HHHH]EU))O*@EI&5QA79F/0X"A1VS72T44 %%%% !1110 4444
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MV]._TH ;]F'_ #UF_P"^S1]F'_/6;_OLU-10!#]F'_/6;_OLT?9A_P ]9O\
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MLC?"X2HJG-+2Q<HHHKG/=&1=&S_>/\6?\_2GTR+HW^\?X<4^@ HHHH ****
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MI_>D_P"_K?XT^+_4IGKM';'Z=J=0!%]G3^])_P!_6_QH^SI_>D_[^M_C4M%
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M_P E.\5?]>MA_*:M/Q9_R*.I_P#7NU9FB?\ )3O%7_7K8?RFK3\6?\BCJ?\
MU[M6U3XUZ+\D8+^%+Y_FSPFBBBN@^5"BBB@ HHHH **** "NH^'7_(ZVO^Y)
M_P"@&N7KJ/AU_P CK:_[DG_H!J9?"SHPW\:/J>S4445QGU)P>L^"-4U2[U3$
MMGY=PMRT5P\C&64R0[(XG7;@)&^&!!)RBD ')JO=^ -8?3[RWL=1AMUEV>7
MC[8@1:&)B<)N!\P[N#C')YKT2B@#@8/!&K'6K+4)'LK86PMU-O$ZL&V3R.Y#
M+"FW*LOW0-VTJV0<TV[\%:Y<:A?2PR6-NLES+,DR7#^9<*TL;*D@\OY0H0XP
M6Y(Z#->@44 >97/@3Q7/8NEQ?Z;>275U]MG3>\2QRM#,CA2Z2AE&^/:=J\1Y
MP"<U<@\":F]OJ,&HKIUPT\\4L-PS[F^5DW @Q;AD*P_UC=<<9)KT&B@#SAO
MNM1QZE'##IK^=J$MS;,;D* C,^U74VS9"AA\I+#C(VD UI>*/!=YKDQG@:Q6
M<Z#>V!D92A^TRB(12# ) 79)SG*[N,Y-=K10!YT_@G7&M+Z/[/I3/=Z:;2)G
MN2/L,F)?GCV0*#N\Q<X5#\O);BF:K\/O$5Y>S7%KK^Q_L+PPR2/_ ,M#$J89
M50*4X;_:&01R!CTBB@#@)/!^O+="6W.GAX+@SB?[3(KWH-S',L<O[L[514*
MY?H. ,BGW/A#7[Z\NYGN;6SDG6=_M$-P[R.9(@@@;Y%_=HW(8'/RK\H))KO*
M* /.)_!7B.XN$G9-)CCCGWI8138B1,2_+DVY4X,@.3'V]0#6]X7\/ZCH^KW\
MUTEK';7!+(J3>=(6+EN6\I"% . I+@=!M  KJ:* "BBB@"*U_P"/.'_KFO\
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MO^_[_P"-'V.+^]-_W_?_ !J>B@"#['%_>F_[_O\ XT?8XO[TW_?]_P#&IZ*
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M^]-_W_?_ !J>B@"#['%_>F_[_O\ XT?8XO[TW_?]_P#&IZ* (/L<7]Z;_O\
MO_C1]CB_O3?]_P!_\:GHH K_ &*'<#F;(X!\]_\ &E^QQ?WIO^_[_P"-3T4
M0?8XO[TW_?\ ?_&C['%_>F_[_O\ XU/10!!]CB_O3?\ ?]_\:/L<7]Z;_O\
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MN$SMR&1C_$>_>H?^$(N?^AS\2_\ @1#_ /&J**T]K,S]G$/^$(N?^AS\2_\
M@1#_ /&J/^$(N?\ H<_$O_@1#_\ &J**?M9_TD'LHA_PA%S_ -#GXE_\"(?_
M (U1_P (1<_]#GXE_P# B'_XU111[6?])![*(?\ "$7/_0Y^)?\ P(A_^-4?
M\(1<_P#0Y^)?_ B'_P"-444>UG_20>RB'_"$7/\ T.?B7_P(A_\ C5'_  A%
MS_T.?B7_ ,"(?_C5%%'M9_TD'LHA_P (1<_]#GXE_P# B'_XU1_PA%S_ -#G
MXE_\"(?_ (U111[6?])![*(?\(1<_P#0Y^)?_ B'_P"-4?\ "$7/_0Y^)?\
MP(A_^-444>UG_20>RB'_  A%S_T.?B7_ ,"(?_C5'_"$7/\ T.?B7_P(A_\
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MXE_\"(?_ (U1_P (1<_]#GXE_P# B'_XU111[6?])![*(?\ "$7/_0Y^)?\
MP(A_^-4?\(1<_P#0Y^)?_ B'_P"-444>UG_20>RB'_"$7/\ T.?B7_P(A_\
MC5'_  A%S_T.?B7_ ,"(?_C5%%'M9_TD'LHA_P (1<_]#GXE_P# B'_XU1_P
MA%S_ -#GXE_\"(?_ (U111[6?])![*(?\(1<_P#0Y^)?_ B'_P"-4?\ "$7/
M_0Y^)?\ P(A_^-444>UG_20>RB'_  A%S_T.?B7_ ,"(?_C5'_"$7/\ T.?B
M7_P(A_\ C5%%'M9_TD'LHA_PA%S_ -#GXE_\"(?_ (U1_P (1<_]#GXE_P#
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MU1_PA%S_ -#GXE_\"(?_ (U111[6?])![*(?\(1<_P#0Y^)?_ B'_P"-4?\
M"$7/_0Y^)?\ P(A_^-444>UG_20>RB'_  A%S_T.?B7_ ,"(?_C5'_"$7/\
MT.?B7_P(A_\ C5%%'M9_TD'LHA_PA%S_ -#GXE_\"(?_ (U1_P (1<_]#GXE
M_P# B'_XU111[6?])![*(?\ "$7/_0Y^)?\ P(A_^-4?\(1<_P#0Y^)?_ B'
M_P"-444>UG_20>RB'_"$7/\ T.?B7_P(A_\ C5'_  A%S_T.?B7_ ,"(?_C5
M%%'M9_TD'LHA_P (1<_]#GXE_P# B'_XU1_PA%S_ -#GXE_\"(?_ (U111[6
M?])![*(?\(1<_P#0Y^)?_ B'_P"-4?\ "$7/_0Y^)?\ P(A_^-444>UG_20>
MRB'_  A%S_T.?B7_ ,"(?_C5'_"$7/\ T.?B7_P(A_\ C5%%'M9_TD'LHA_P
MA%S_ -#GXE_\"(?_ (U1_P (1<_]#GXE_P# B'_XU111[6?])![*(?\ "$7/
M_0Y^)?\ P(A_^-41^!%_M&QN[WQ'KFH?8;@7$4-U-$T>\ @$@1@]&/?O111[
,68>R@=711161H?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>genp.jpg
<TEXT>
begin 644 genp.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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BH%%%%9F@4444 (% Z #\*6BB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>lun.jpg
<TEXT>
begin 644 lun.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M_P ^5M_WZ7_"C^S+#_GRMO\ OTO^%%Z?9_U\@M/NOZ^8S_A-_"G_ $,^C?\
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M_P!^E_PH_LRP_P"?*V_[]+_A1>GV?]?(+3[K^OF,_P"$W\*?]#/HW_@PB_\
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MQK#EE:]M#;F3=DRT2%!)( '))J*UO+:^A\VRN8KB/.-\4@=<_44E[_QXS_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#GK'_ )*]>?\ 8"@_]'RUV%<?8_\ )7KS_L!0?^CY:["M
M:FZ]$9T]GZLYCXC?\B#?_P"]#_Z.2N ^/G_(O:5_U]-_Z!7?_$;_ )$&_P#]
MZ'_T<E8GQ)\%WGC72[.UL;F&W:WF,C&;."",<8!K:A)1<9/:[_0SJQ<E)+LO
MU.=M_AAK%]H<)7QQJBK-;JPA8L4 *_=^_P!.U5OA7!%#)XB\$:M9VS/%N$LL
M8R9ESM()]LC'IFM!?!_Q*6S6U7QC:I"J",!(<$*!C@A,_K6YX!^'Z^#C=W5S
M?-?ZA>?ZV8K@ #G SDY)ZGOQ6LZBY))R3OM8SC3?.FHV."\$>)Y? G_"3>']
M6D &G))/:JX^\XXP/][*D#ZUT7P5T.6'1+SQ!?JQN]4F)5W')C!SG\6)_(5R
M_P 3M'M=>^+MAI>G%Q>7:1I=D %5]_J$&3[8KW"UMHK.TBMK=0D4*+&BCLH&
M!1B)KDNMY:L*,6YZ[1.>\?:-I^J>#]2FU"TCN);.RGEMW<<QMY9.1^('Y5Q/
MP0T/2[GP_)JT]G$]_;WS+%.1\R#RUX'YG\Z]5O;2._L+BTGR8KB)HG _NL,'
M^=>>^#_A_P")?!NM;+'6[:;199?,N(6C(=P!@8&" >F2"*QIS7L90O9FDX_O
M%*USEOAEX4TKQ%XG\0W.LVXNDL[C$<+GY,LS\D=\!>/J:G\%6D6B?'O4].T\
M>3:!)5$0)("X5L?0&NX\!>"KSPE?:U/>7,$ZZC,LB"('Y0"YYR/]H?E5?3?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3Y+GZ_P_CQ[UYU;!U*>JU1V4\3&>CT9Z91117$=04444 %%%% !12,P126(
M'<U5DU.V3HQ?_=% G)+<MT5G'6%_AB)^II@UC_IA_P"/_P#UJ=F1[2/<U**S
MUUB(_?C8?3!JS%>P3'"2#/H>#19E*47L3T444B@HHHH **** "BBB@ HHHH
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M46'<O3IE,]Q56KS#*D52I )1110 4444 %%%% !1110 4444 %%%% '/6/\
MR5Z\_P"P%!_Z/EKL*X^Q_P"2O7G_ & H/_1\M=A6M3=>B,Z>S]6<Q\1O^1!O
M_P#>A_\ 1R5L5C_$;_D0;_\ WH?_ $<E;%)_PUZO]!KXW\OU"BBBLRPHHHH
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M;*?1JA;CG\+,*;[H^M0U--]T?6H:U.,*5)'B</&Q5AT(I*? (VG03L5CS\Q
MI#ZFCI8E$CWEP[")5.68_>-.T9\WEQ)C&5)Q^-/NYK*Y18UN_+B4<(L9JO83
MV]I<SYERA3"-M/-2;;-#YK%;C4(GB_U,XWD^GK4NJRK/IT+1#"^857'MD51A
MU&6&Q>V4<-G#9Y7-++/&VDPPJV9%<DC!XZT68N:-G8FMM-D,%QYT!W[/W>?6
MJ,UO+;L!,A0D9 -3V]YY4,ZR,Y,B87G.#55F9C\S%OJ<TU<A\ME82BBBJ(.6
M^(SE?!=P!_%)&#_WT*\7KVSQ_#YW@J]Q_!L?\F%>)]J]'"_ <-?XC6^&]NEQ
M\4=&CD^Z+HN/JH+#]17U<.E?(G@F^%A\0-&NCPJWL88^S-M/Z&OKM?NUEF%^
M>/H>A@_A9C>*O#-CXMT*72M3WB)R&5XSAD8=&%>7GP?\2? MJ5\*:PNIV$1)
M6U*C<!U.$?./HK5Z+X[TK7=8\.FV\+WXL;T2K)YA<IN49.W<.F3C^5>:WOQ
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M2PGYB*9F;&B_\?$G^[6E/9VUQ+%+<6\<LD#%HG= QC.,94]CCTK.T4?O93Z
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MP%;I95^10?*8!1L8+SCGH?2J*^$=0UGP3K\E_&L&MZ^&E*2'/V=0,0PDCLH
MSCN6JXB:WXB\3:'=7^A3:3!I32SS-/-$_F2-&8PJ;&.1\Q.3CH*IV8E=':=J
MIM]]OJ:N=JI$Y8GWK(U$HHHH **** "BBB@ HHHH **** "BBB@#GK'_ )*]
M>?\ 8"@_]'RUV%<?8_\ )7KS_L!0?^CY:["M:FZ]$9T]GZLYCXC?\B#?_P"]
M#_Z.2MBL?XC?\B#?_P"]#_Z.2MBD_P"&O5_H-?&_E^H4445F6%%%% !1110
M4444 %6X&W1@>G%5*DA?:^#T- %NBBB@ HHHH **** "BBB@ JO?1>99R+WV
MY'X58ILC!4);IB@35T<A*V6QZ"F5+=1&&X=#ZY'TJ*M3B>X4444Q!1110 44
M44 %%%% !1110!G:]:?;_#]_; 9:2W=5'OM./UQ7S[,VV%S[5])5\]>,K$Z1
MXBO+$C $I=/]P\K^A'Y5WX-W;B<N(C>S,".1X9DDB8JZ,&5AV(.:^RM"U)-8
M\/V&HQ$;;JW27 /0D9(_ U\9U[U\"O%\=UI3>&+HXN+3=+;DG[\9.2H]P3GZ
M'VK7'T^:"DNAKA)\LW%]3V&LJ_\ #6D:GJUIJ=_9)->V>#;S$G,>#D8P<=:U
M:*\9-K8]-I/<****0PHHHH **** "BBB@!"< FOD7QWKQ\2>-M2U'(,;2F.'
M!X\M?E7\P,_C7T1\4?$Z>&?!%XZOMN[Q3;6P!P=S#!;\!D_EZU\KUZV7T]ZC
M]#S\9/:)H6C;K<>W%>T_#:S-MX021A@W$SR<]QPH_P#0:\4TB*2[U"*SA&Y[
MAPB#_:)P*^D;.V2RLH+6+A(8PB\=@,4\:[)1.2A'WFR:BBBO..P**** "BBB
M@ HHHH **** "G1G:X--IR(9'"J,EC@4@.CT>(I;%S_&?TK1J&VVK B+_" #
M4U9';%65@HHHH*"BBB@ HHHH **** &R-MC)JE4T[Y;:.W6H: "BBB@ HHHH
M **** "BBB@ HHHH **** .>L?\ DKUY_P!@*#_T?+785Q]C_P E>O/^P%!_
MZ/EKL*UJ;KT1G3V?JSF/B-_R(-__ +T/_HY*V*Q_B-_R(-__ +T/_HY*V*3_
M (:]7^@U\;^7ZA1116984444 %%%% !1110 4444 689<C:QY[>]350JQ'/Q
MB3\Z )Z* 01D'-% !1110 444UI%0?,: '$X'-5)9/,;V'2B24R>P]*CH I:
MG;^9")%&63^58]=*>:Q[^R,3F6)?W9Z@?PU<685(?:12HHHJSG"BBB@ HHHH
M **** "BB@ L0%&2>@I *B-(ZH@R6.*X?XT^$(WT2WUZSC)FM,0W!'\49/#'
MZ,?_ ![VKT^PL_(4O(/WC=O[HJ>[M(;ZSFM+N-98)T,<B,.&4C!%.G5=.HI(
MW]CS0:?4^.!TK1T'6KKP[KUKJM@P$]L^Y0>C#HRGV()%:GCKP=<>#?$#6;[I
M+23Y[6<_QIZ'_:'0_@>]<W7T47&I"ZV9Y+4H2MU/L'PMXFL/%>@PZGIKY5QB
M2,GYHG[J?<5M"ODCP5XUU#P3K/VNR_?02#;/;,V%E']".QKZ8\*^,='\7::M
MUI-RI?'[VW<XDB/H1_7H:\+$8:5&5UL>K1KJHK/<WZ***Y#I"BBB@ HHHH *
M@N[N"QM9;F[E2&&)2[R.V%4#N35;5]9L-"TZ2^U6ZCMK>,9+N>OL!W/L*^=/
MB9\2Y/&=RMGIHEM])A;(5CAIV_O,/0=A^/TZ*&'E6EIMW,:M:--:[F3\0?&E
MQXS\227.XK8P$I:0_P!U/[Q]SU/Y=JY6BM#0]#O_ !%J\.G:7"99Y3^"#NQ/
M8"OH(J-.%EHD>.W*<K]6>@?!;PC_ &IK$FO7B_Z-8DQQ C[\I7G_ +Y!S]2*
M];N;=K:8HW3J#ZBKWAS0[?PWX?M-*M "EO&%9P,;VZLQ^IR:MWMJ+J' P''*
MFO K5O:U'+H>I&BHT[+<P**?)&T4A1QAAU%,K,R"BBBF 4444 %%%% !1110
M 5I:7:Y;SW[<+[^]5K.S:ZD](QU-;J*$0*HP , 5$F;4XWU9)&_EMG\ZMJP9
M<CI5&GI(8VXZ=Q4'27**8DJN.#SZ4^@ HHHH ***,XH *CFEV+Q]ZFR3@9"<
MGUJN3DY/6@ ZTE%% !1110 4444 %%%% !1110 4444 %%%% '/6/_)7KS_L
M!0?^CY:["N/L?^2O7G_8"@_]'RUV%:U-UZ(SI[/U9S'Q&_Y$&_\ ]Z'_ -')
M6Q6/\1O^1!O_ />A_P#1R5L4G_#7J_T&OC?R_4****S+"BBB@ HHHH ****
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M_P#HY*V*3_AKU?Z#7QOY?J%%%%9EA1110 4444 %%%% !1110 4444 %%%%
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M4,IR",@YZU\F:)X5UC7]4CL;"QF+LVUW:,A8AW+'L!7U7;6,=O:Q0J9"(T"
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MCTJM/XKMAK&@VEB([R#6O.\NZBE!51&F[(QG=GIU%'*PNC>HH^G2BD,****
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M%5(?$^D3^(KC0X[R/[=;JI:,L!G=G@>I&.1VI.4FK%*,4[W->BBBLRPHHHH
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ML\DEG//;R-<&X1E*GRR0P*@$$;?G<X_VC1^[MYA>I?0N3:S96^GQ7LDI,$Q
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ME[.V@1]I?4K:=X@M=2G6"!9#+Y222,L;&-"RA@N_ &<$4C^)=.CN9X97EC,
MD+,T+!6,8RX4XP2!S@4ZST"WLKN">.65C;Q"&,,%X4*%Y(4$],X)QGM55/#4
M=PUP^H22MYDDYCC##;&),@D<9W;3CG(&31^[O<?OV)X_$UA)<QP@7"M)MY>!
MP$W$A0QQ\I;'&?4>M-M/$]C<-:QNQ22X4$$*Q12<X4M@8)VG -27FC(\LUU
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MKS_L!0?^CY:["M:FZ]$9T]GZLYCXC?\ (@W_ /O0_P#HY*V*Q_B-_P B#?\
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MJT@ 4"'<<Q]ER,^9GVQCFKDMW)#XRM5CNVD@N@Z-&LP< A<@;,#8!C[P)R2
M>M; FLIFAD!B<W2?NWVY\Q<9Z^F*9/>Z?97#><T<4K!MQV\D*NX\X[#FCFN]
M@Y;=3G[C6+FV_M!!<0R*;BXC$0)$L>(F?=G=P/E].X.:JW6HW44]P_G38 ;Y
M1*PQ_P >GO\ [3?F?6NQC%M,6DC6-CRI;;R?44\Q1'K&O_?(]O\  ?D*.=+H
M'(WU.;;Q'> #RS:.TV[;$ =T&)53#_-S][T7D=ZL7.HW7]@:LTS(9[-VC#P[
MHPWRJV>I(/S8ZUL1&VE>4PJC,K[9"%YW#UJ;:I##:"&ZC'6ES+L4HON85EK%
MY)J\%O.L!@N6N0@16#)Y,FT9))!R/88K>IHC0$$*H(SCCIGK3JB33V*BFEJ%
M9ESJ3PZR+<R01110"=O,7+RY+#"<CIM]#U'%:=-:-&969%++RI(Y'TI)I;A)
M-[')#Q7>R6TLT(M3%$5D=RHW>44W<)YG)_X$#@],\58C\0ZE=37?V:*T\N)I
M(T\QU4@JV 3\^>>3C"]5YYS71?9;?:!Y$> <@;!P:5H(79F:)&9AM8E021Z5
MKSP_E(Y9]S%;7)1X=BO4> 2/<+ S2IM1"90A)&\]/9N:IIXFOY;Z"VBMX&SN
M+2[@JR@3&,E,L,<+N_BZ@8[GH[BRM[FW2"6,>4CJX0< %2"/PR.E2&&(J@,:
M$)]T;1\OT]*2E!= <9]&9%OJ&HSZ#<7Z+;M*K.8H55AE4<@@G/)(7\/>J!\3
MWDTMJ+.WA,5R'EB>0@;XPX4 $L.2/F[\$<=3723VRSVS0[GB5N\3;2.<\$=*
M2.T@BMXH$A010J%C4C(4#@8S0I070'&71G*R^+[IA*]HEO(K-%Y)==N TPCY
M <GH<]%.1TJ[K>I7>FW]IL97D^QSN1EEC9E,?)7/O[FM\00KG$2#)R<*.33F
M16.656XQR*.>-[V'RRMJSG]3U34;30=9<2PBZL<;)4B.#E%;.TD\_,>_:HXM
M2O[6ZO)?.@NK?[9'%L5#ELP1GY#N( R<XP>IYKI2BD,"H(;[W'6D6*-%"I&J
M@<@!<4<Z703A+N8NAZK?:K:32W$<*#RD>(PL,Y8$D$!FZ8'/&?08J/2=5^T-
MIYDNU=?[.#W&7'$A* ;O0YW#\ZW4BCBW>7&J;CEMJXR:!#$-V(D&\Y;"CYCZ
MFES1ULA\LM+LP-'N#;:M/%>WQN))076070>(C>% V\;&RP '(/K715&MO"F[
M9#&NX[CA0,GUJ2IE)2=RHII6"BBBI*"L?4]-M;O7M/DGM(I21('9H@W11M!X
M_*MBHI+NVBG6"6XB25QE8V<!F^@[U46T[HF235F<C%>:OINFI%;EY%-H)1OA
M_P!3^]"MC"DG"$G!#'C//2M*&>ZOM"M)+J19Y/MT?SQQLN5$HP2"J]NIP!Q6
MW)>6T<9DEN(D0*&+,X  /0Y]\?I3'U&T6*.3[1&R2'"LK@@\XS] 3R>U:.5^
MA"A;J<W%K>I716&$R)(D4"3.;<_)*TZH^,CG"Y]N],O-;OK:XM;>>_:W#2RK
M),8A]Q9]H+?(0,IG!PHSS[5U,E]:0QF26YA1  VYI !@]#GWYQ5%SI.I7-VU
MQ%&YL66.5Y.%QM#C)Z$8;/-.,E>]B90=MR*^U"2WUQ(9)YXH3$KPI#"&$[Y;
M<I;:<=%]/O=?3)TS5M6U.Z6$3SQ1/*G[WR1N0&.1BN3&HX*J.AQG&373?VGI
M^0!>VQ)4L )5Y ZGKVP?RI8=2LKA(&ANX7%P,PX<?O/IZU*E9;%.-WN<U:ZU
MJ<MNAN7ECO/LF^"!;;"7$F&SN.TXY X!'ZU/I=]J=\MH&NV*23L'=8CN"A <
M'<B@'=GD+TXZUO3:A:6\C+<SQP[<9,K!1SG')_W32S7]I!'"\US$B3L%B8L,
M.2,C!^E/GTV#E\SG->@F_M]KB-&EP;)$S"K!09VW$''&  >O'?M39M6UE=-,
MS@P>7<+;2OY?3:K;I1\K<,^T=",>F<UT-KJUC=QR-%<1CR2PD5G *;6*DD=A
MD&I6OK9;5+@2J\+LJJZ'<"68*,8]S0I-630N5/5,QM1U;4=-T>+49H(YHXUC
M\Q8"<S%EQPI4%?G*]\XSFJ']KZS:W\L=[)O:",LT$<9)E AW93"8SNS_ !8X
MQC-=!>7&GXFEO2NW3\32,P.(^,AO?CFK%I=I>P>;$DJ+GCS8RA/O@T<UEL'+
M=[G-:+J>K:G>>3--(D"3R 2B( R(%C8<E%X)9AG:,CISS765674+0LJ&>-'>
M1D1'8*SLIP<#OS5FHF[O:Q<%9;W"BBBH+.>L?^2O7G_8"@_]'RUV%<?8_P#)
M7KS_ + 4'_H^6NPK6INO1&=/9^K.8^(W_(@W_P#O0_\ HY*V*Q_B-_R(-_\
M[T/_ *.2MBD_X:]7^@U\;^7ZA2-]T_0TM%9EG!Z?HNISZ/%);))%#-;6[2QR
M7!<W# [F8?-QD>I&>AK>T;1Y[:[CGO7FE,-JD41EDR0=TF<@$@G:RC// K>
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M<_W?#W_?<_\ A76T4<_D@Y7W9R7D>.?[OA[_ +[G_P */(\<_P!WP]_WW/\
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K<KH.AZW%XLNM;UZ33PTEC':)'9%R,*[/D[@/[U=5114RDY.['&*BK'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>our.jpg
<TEXT>
begin 644 our.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M_A1_PL_P7_T,5G_WT?\ "MRBB]/L_O\ ^ %JG=?=_P $P_\ A9_@O_H8K/\
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MHHO3[/[_ /@!:IW7W?\ !,/_ (6?X+_Z&*S_ .^C_A1_PL_P7_T,5G_WT?\
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M X'!V'GT8C^M'-3[/[_^ /ZI4_G7W?\ !/0O^%G^"_\ H8K/_OH_X4?\+/\
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M"]*+T^S^_P#X 6J=U]W_  3T+_A9_@O_ *&*S_[Z/^%'_"S_  7_ -#%9_\
M?1_PKSL/GM4NX!>*+T^S^_\ X 6J=U]W_!.__P"%G^"_^ABL_P#OH_X4?\+/
M\%_]#%9_]]'_  KS_-!.!1>GV?W_ / "U3NON_X)Z!_PL_P7_P!#%9_]]'_"
MC_A9_@O_ *&*S_[Z/^%>>XI#FB]/L_O_ . %JG=?=_P3T/\ X6?X+_Z&*S_[
MZ/\ A1_PL_P7_P!#%9_]]'_"O/1Q3PU%Z?9_?_P M4[K[O\ @G?_ /"S_!?_
M $,5G_WT?\*/^%G^"_\ H8K/_OH_X5PZ/D5(5XHO3[/[_P#@!^\[K[O^"=I_
MPL_P7_T,5G_WT?\ "C_A9_@O_H8K/_OH_P"%<4.M.SCI1>GV?W_\ /WG=?=_
MP3L_^%G^"_\ H8K/_OH_X4?\+/\ !?\ T,5G_P!]'_"N/#-2T7I]G]__   _
M>=U]W_!.O_X6?X+_ .ABL_\ OH_X4?\ "S_!?_0Q6?\ WT?\*X\T8HO3[/[_
M /@!^\[K[O\ @G8?\+/\%_\ 0Q6?_?1_PH_X6?X+_P"ABL_^^C_A7(@9YI=M
M%Z?9_?\ \ 7[SNON_P""=;_PL_P7_P!#%9_]]'_"C_A9_@O_ *&*S_[Z/^%<
MNAQ5A>:?[OL_O_X _P!YW7W?\$Z#_A9_@O\ Z&*S_P"^C_A1_P +/\%_]#%9
M_P#?1_PK#!%+3M3[/[_^ '[SNON_X)M_\+/\%_\ 0Q6?_?1_PKJ()XKFWCGM
MW62*5 Z.IR&4C((_"O,]6'_$BO\ _KVD_P#037=>%?\ D3M&_P"O"#_T6M*4
M8\MXCBY<UI&9\1O^1)F_Z_+/_P!*HJV:QOB-_P B3-_U^6?_ *515LU+_AKU
M?Z#7QOT7ZA1116984444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y#XDF;P
MMXUFA)VVMU^_ [;3V_ Y%>O5YY\7]$-_X?@OX ?,M9 KD#^!O\#C\Z4MCIPT
MDJEGU*Z-'>64=S;G(/('<CT-3Z?<A/D'(_AR><=Q]:X#PEXB:*Y2&8[A(WEJ
MOH*[6Z$=O()4?,4A&6!^ZW8TD[G?*/*[,/$$'EC[1&/D<%3SQR/\:KZ/J,<T
M:.#DM&#CW'7^=:,Y^V:+,KX+Q@G ]1S7$:1>_9+Y87) 2X90"?X67/\ 2AZ,
MI1O$[^YC6: 2( <C&<?Y]JS9(RR%3P6S@_49_F*OV$IEM1$#U''/<<?X55DS
MNV$88=#C\1_6F0BDR[I 5_BRIQVW#/\ ,&G<E,\G/S(![X/\U-.<; ^W &,@
M@=<?,/YTQ@JKP,[1C@]@<_R)H&-=@9,X(W9 ..YPP_K3@!N!3G=QU[9_P:F%
M1$Y7NHXY_N\C]#4KK\O)R 3@ _4?U% #MN]E;D=&Q[\9_K0[8;CJ1DX_E_+\
MZ=(0,AAQT&!T//\ B*BD<-CCD?KGI_(4"+"L#SVQS_GVJM*JBX4-P"VX>XY'
M]:F& F#\N!U_K^5(Z#$3[\G=@X&>.O\ 2D!!=L!:6Z?Q<EO8FJ+59NY"[)E=
MO&<?6J;'YJH\NKK-@?:@'UIO4T[;2,Q>KBIY/EC%0HN&R33W?S#BF Q#@U*&
M!J$C:<4_.!0!(6 '-+D$#%5V=C4BL%7+''UH =NRW':GKSUJN)X5?!D7_OJG
M>?$>DB_G3$62M(5)Z5"+F,=9%_.E6ZC+?ZQ?SH D"X;FI H-1&XB_P">B_G3
M1=1CK(OYT@'MQ2$TQIXF/^L7\Z;YT1_Y:+^= R9#ZT$\U%Y\0_Y:+^=.$L3#
M_6+^= #\T[%1>;&O\:_G3TFC8??7\Z +$:XQ4X;*XJNDL>!\Z_G3A-&&^^OY
MTQ$VVE P:B^T1Y^^OYTX3Q$_?7\Z8$P%&* P/0YIU "%?2@ U(*6@"/!I<<5
M(!FG[1B@",?+4R-D5"P/:I8AQS0!*!GI3U'K3 V.E+F@"#5SC0K[_KVD_P#0
M37=^%?\ D3M&_P"O"#_T6M<#JW_(#OO^O:3_ -!-=]X5_P"1.T;_ *\(/_1:
MUH_X?S)^V9GQ&_Y$F;_K\L__ $JBK9K&^(W_ "),W_7Y9_\ I5%6S4O^&O5_
MH-?&_1?J%%%%9EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45S;QW=K+
M;SKNCE0HP/<&I:*!IV/E?6+6X\/>)[FS+$2V\AC!]_7\J]%\+:E%J&G?97.]
M N'9O6J7QQT$V>H6VN6_$=TWERCTD ^4_B!_X[6%X+N6D1H@VV)"-_JQSQ6*
MT=CVE)5*:D=O;W9L[I()CG+>4X)ZC'RG\JXKQ"DFE>(B2#LW)(I"XR.1_6M7
MQU/+9R:=J$3;%E=8W]B#\OZ5G^-I!J&DVNHP88*SPGWZ$?R-5(JGH_4Z[1;D
M.H;.2LA'IP1FM:Z XDQ@=2 .?\]:XCPU>;DD..,1L!UR< 5VR,9(!\OS#IGV
MJD[F4E9E%P!D'MRO'7;_ /6-,8KMYX"'!/KC(_D?TJ20A,G. HR.>W<?D:A,
M:[LL3V!'7)'RG]"*8"K'C&[DJPR?4 X/Z$4X$B,Y;)&,_EG_ -EI,MRI')X/
M;G&/Y@5-LW0ENA_/&3_]E0!"K@J"0"0._J.O_H-0/ECA6^;H,<=L#]5ISM@D
MG!&02?8__M57);=D9#$CCZ\_^A _G2&D7X6&!ALCJ!V(J6/#(RG)'7FJT:C;
MF/YNZ@]P>@_4#\*M1?ZT[B<XQ02S,O3O8/[8JGRQXJU(2UG!GD@%2?7!JJ5*
MBFCS*NDV(#@T\D'I45"D[J#(F_A-(G'-(7XZ4*<T 2GIFF,^!2,U-(R.: *M
MW?""-F]!7F?BWQ7J+1.EO.T:Y_AZUV^MR!(7^E>3>('W!OK2ZB9VFC_#_7_$
M&CVU]9:I(@D0,=SGGBKO_"IO%PZ:PW_?1KT3X6G=X&T__KD/Y5VP%;6$>"GX
M3^,/^@N?^^C3#\*?&0Z:K_X\:]^ I<"E89\_'X6^- >-4)_X&::?A?XT[ZD?
M^^S7T'@4;11RBL?/G_"L/&G_ $$C_P!]FE_X5?XU/34O_'S7T#M!I0HHY0/G
M[_A5WC7_ *"1_P"^S3A\,/&W;5"/^!FOH# I<"CE&?/_ /PJ_P :GKJA_P"^
MC2K\+_&HZ:H1_P "-?0&T4H HY16/ E^&7C<#C5V'_ C2_\ "LO&Q_YB[?\
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M]7^@U\;]%^H4445F6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9>(S(W[T \=ABO,+"1MBC..E=3I[#CYJ:J2'*C$]!@O8;@#:V#Z&K%<M:2D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /5_^K/Y5EV[ML,8'\+ <]U/%:4;9^[R"=P [@\_S%69V' LK#<,G/;IG_\
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MR35Z-Q"HBCZ_\M#ZGT_"J:G:0X^\>%^M7+>(*H!/0=:F3)+46H^7)M5&E?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY9@0%_><\"O1?#6MMKMJS.BI+'U /#'VKR68PM:Y? =/E!_&K^C:W>:8P6T
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M* /H*Y2'P&D7Q/G\8_;V+S1>7]E\K@?($SNS[>E==64Y7M8T@K7N>6_M _\
M)/+7_L(Q_P#HN2N6\2I??#^\\.>.-#7,5[80P7T)SM=O*7@_4 'ZIFO5/'W@
MQ?'.@1:9)>FR$=PL_F"+S,X5AC&1_>K:L=,BM=$M--F"W,=O!'#F1!A]J@9Q
M^&:J,THI$R@W)L\#U#PM/I_P8U/Q+JS^;JFN7$-PY(Y1&DW#\6)W'\/2KGQ
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M_JO+^]G\>E=K43DI6+@FKA1116984444 %%%% !1110 4444 %%%% !1110
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M-O7:'7^M>C_$.<IH[16;)+97$$<S$<[7W$9!]\BN6O-,DBBMY$C.X6JS<#J
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MB$^G7P]+64_^.FO4O"O_ ")VC?\ 7A!_Z+6O+ Q6SO\ '_/I+_Z :]3\*_\
M(G:-_P!>$'_HM:ZH?POF8R^/Y&9\1O\ D29O^ORS_P#2J*MFL;XC?\B3-_U^
M6?\ Z515LU3_ (:]7^@E\;]%^H45QVG^+[VZ\=S6$MO"NB2R26ME=C.^2YB
M,BGG&/O@<?P&M_5?$.D:(T2ZOJ-O:-+DHLL@!8#J<>@]:AQ:*YE:YI45SWAG
MQ/%K-L3<W%LLTM[=0VJQM_KDBD*@KR<_* 21ZUHWFO:3IWG_ -H:C:VWV<(9
M?-E"[-^=F<],X./7!H::=@NK7-"BLRW\2:-=:9+J-OJ=K)9PG;+.)1MC/'#>
MG4=?44:;XET76+J2VTO5+6[FC&YHX90Q SC/N,\9Z46871IT5CCQ7H<VH/IU
MMJ]D]\"46$S#[X_A]R.XZU!:^*+&TT'3[GQ%JVF0SW4'F;X)<12],F/=R1\R
M_G19A=&_16='X@TB71VU:/4K8Z>N=USYHV+@X()['/&*;IOB31M9E\K2M4M+
MN787,<4H9@H(!)'4<D?F*+,+HTZ*S]2U_2='<)JNHVUHQ3>%FD"DKG&0#UY(
MZ4#7]).BC5_[2M?[.(R+KS1LZXZ^N>,>M%F%T:%%9,'BO0;FR^UP:O9O;^<L
M!D$HP)#T0^A/H:NS:C9V][%9SW44=S.K-%$S@,X498@>@HLPNBS167IWB;1-
M7NFMM+U6UNYE4L4BE#$@'!(QU'N*B\):M/KOA.PU.[6-9KF/<XC!"@Y(XR3Z
M4<K"ZN;-%8<OC7PS#<302Z[8)) 2)%:=1M(."/KGM5C4?$^B:3=+;ZGJEK:S
M, P224 @'H3Z#W/%%GV"Z-2BLS4O$FC:.RIJFIVUJ[('599 "RYQD#J13G\0
M:0FD)JK:E:C3Y/N7/FKL?G'![GM@=Z+,+HT:*JZ?J=EJUF+K3+J*Z@)(WQ,&
M&1U'U]JQ8/&VF7'BS4-!6>W%Q:HGEGS@3,YW[DV]BNP9Y[T6872.DHKE?"GC
MK3-<TK2UN]2L5U:[@1WM8I ,.5R5 )Z^W6M:\\3Z'I^HK8WVJVEO<G'[J28
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MK67;QSP%I)K0H&Y$B?-@9Z<>F*W-/=69'7<RX)#$=*LDV,T9J#S/>@/FF,L
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M(..N,9JHRI73Z"<:EO,QSXZ\0:KX@T?3-"MM/B.IZ2E\7N@Y\ICNR/E/(^7
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M("JLQ_B;BO1-%CPJY%<9HL&R&,>PS7>:.F$%<,W>1Z4%:*1T]N,(,5T>DOM
MSZUS<>%4>];VE/P*TB2S&^,MJT_P_>YCY>TGCE4^G.W_ -FKR[0]2^U6XW<2
M+PPST->\^)]-&K^#]0LF&3+;L%'^T!D?J!7S-]J.ESQ7,8/E2D*X_K14C<TI
M2LCO8YR5[UHV=\89.M<];70DC#*<@BK*RE3FN;8Z'JCTK2=562,*QR#P0:O3
MVR)9SF'.UE)V@=/I7GVG:@8Y%Y[^M=GIVJ>8H!;MZUM&3.:2L>#6:+JNCO:*
MVVX@9BB;3@$#)7VS@_C6=#M%_!:S%''^L^7G'UKWN]\%Z==ZDVIZ;_H=V_,H
M0?)-_O#^HKR#6_#MSH7BJ8?8V(>8BV4XPRE2 ,]\>M=,7&6IQS4HZ&X'>XL(
M-+L(%$MP=\CC"M%%]WCT)P?IS7/^+DGT^XT[39KF1K8N)&@)X4+_ )-=#I5C
M>0"?4M;C,-R^" @^7;SA01TXS^=<!XBU.;4=<GF\SSE0&--W-;=#G$D"7&K7
M,Z!W2/$2$]3CJ?SKK]#A3[."Y6.0G!!Z$$]_H,UR-A%'$B)<S^5P2<#)-=-9
MQ64:H)+Y@N"4#YRQ)QG.?3^=2,] TAM[/'"R&3[WS+DJ"<C]#^5:,-M($4O:
M+M<$8+ 'C)SQ]!6)H\=LJR213++(\A&1( VTG''ME0*W;<;U+^9+!+MRKMR/
MIGIR6_2M$!H:0EU!=%()&#L,^1<$D8]B/K7,?$SQGJ/A6:R.G0J'N4.^/).,
M=^*[6W*LJ3R@^8F<;/XOPKF_%B6MS=P/-$L@V97><XR:;V)/,#\7_%#?=@ _
M U&WQ8\6M]V/'T4UVHM; =+:+_OFI%@LA_R[Q#_@-3=CL<&?B?XQ)X#?]\&H
M)/BGXO#;6N"A]-M>C"&S_P">$7_?-4=0\/:??_O%B19!Z#K2U"QP#?$CQ?)_
MR^./H*AE\<>+I@0U], ?0UUK:#%$Q'E 8]JIWVGK!"2L8S]*GF8['%6US>B[
M:>X#,[MEW8\UW6F7<$\D9CG&>_-<D7E82H\7!!&<5SQDN+>4^6SKSQ@FH>I2
M21]6:)+'_P (_(#*I/EGO[5Y7+.FG:FDLR^8O/%>?V'BK6K5/+CN[C9T*[CB
MMNTO[G4OWER-NT<"N>I%MKR.^A*,*<E?<[A?%UFG_+EG\*L#QAI[KS9'\A7"
M2!B>I%30P$J,L:LY['6R>+;4?<LOTHB\8HO2R'Z5S(L<_P 9H^P'^^U*XK'3
M-XNV,6@@$9/4&J]YX^N[>')B&P#YF!Z5SS:?(3\KFJ5[87/DLH.015*1+1'J
M?CF]NM1B:SO&"R?NW3V/!K[)\*_\B=HW_7A!_P"BUKX4CT.XCO(Y".%<$_G7
MW7X5_P"1.T;_ *\(/_1:UV*WLM.YS6:J:]C,^(W_ "),W_7Y9_\ I5%6S6-\
M1O\ D29O^ORS_P#2J*MFA_PUZO\ 0:^-^B_4****S+"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\V^//AM_$/PLO)
M+=2\^F2+>HH[A00_Y(S'\*])IDT*7$#PS*'CD4HZD<$$8(H _/>KFDW0LM5M
M;END4RN?H#6KXY\*S>"_&FH:)/\ ,L$F87_OQMRA_(C/OFL"@1Z7\3%6X.G$
M,  K-^'&*YBSTY)M*N)I&99#\L8]>#U_E6IXJF-Q?6J-SY%M&H'7)(S3+>2*
MW6+<-Y.,C^''7FI$:FB.)84(Z@#-=UI"_(M<[?Z8-.U6.:!6^SW:^8O' /<?
MUKI]*VF->W2N.:M(]*$KQN;0[8K;TH]*Q$Z@5M::<,*I;DO8ZR,>9:D>HKYF
M\;Z/_9NKRZ?@@+<,5!_ND[A^A%?3%JW[K\*\C^).ARZKXHN%M8\W$4*S@YP&
M4C!7Z_)D?C6S5R8RMN>9^']4VYM)>&CX!QU%=,LH<<&N!V,K23Q'#I)D?A72
MZ3J"7<(8<'H1GH:YYQZG1&?1G0PR[""#6[INHB-ADBN95N.]3Q2[36>J&]3T
MJQU)#$.:Y/XISQR:);2H?WD4P93[=ZBLM09% S6#XUO3>68C] :I,S:.P\*7
MW]K^'(7!"R1KL9"1TYK"U/X=Z=',VH65JV]&WL#<$C/7./?ZU'X+O7MO#+"W
M\KS848[7Z-C!/3KQ_*NK74[J\B"M;1HTT)#+Y@/8]R..!FO26J/->YYYJO@A
M+C2OMUA;F"Z1\3+YA=7!&<@<D=/UJ"#PX);..(74(F/"G/3GO^7Z5VNFSW,^
MM26SV_D^6H$CM(,#!ZY'TZ5)J]T%T]]6TY%=4^:XM9 .,9&0,\^I%*P%31-$
MN;&% L<;A(S\P8D8YP?U)KIK!VD,.Y6C9%VNAQR!WQUK$T75HM2M//BA5/G*
M^6K8(SC ';IG\*ZFR26XM%>T<R(6Q^\&[//7G\35(1<M;3RU81Q@E\LN'[]^
M/TKSSQYJD5IJUO$)%C_<[B'(!Y8G_&O08OWBN2&AEA.?E.-W'^?RKP7XIZBM
MUXWN(W0'[.JQ@^O&?ZFE-V0TKLN?\)'#_P _$?YBE_X26W'_ "\QUP N8P,>
M4IIPND_YXK^59\S+Y3O?^$HMA_R\QU+%XMMD/^O0UY^+M>T*_E2_;\=(4'X4
MN<.5'K]E=P:I8F>.56?/0&J6I)B$YKSBU\1W=F,6^U1]*=+XFU"=?GDI-MC2
M1M2HIWXK+>Q0L=PY)]:SCJ5R<G)YIAU"<]:BS+NC=M=(4D-[^M7O*%L^%/%<
ML-3N%'RL1^--.HW!/+$_C2Y6RN=(Z@R?-VJY#*H49(_.N*-].>Y_.D%Y.#D$
MT<K%SH] 2X0=2!^-.^TQ$?>'YUY\;^<]2?SIRW5P>F?SHY0YD=Z+N,?Q#\Z#
M<P2+AI%_.N%$UT?7\Z</M7K^M*Q5SLUM[9XY&:9<A"0-W?%?6'A7_D3M&_Z\
M(/\ T6M?$,(N?,3+<;AGGWK[>\*_\B=HW_7A!_Z+6NJ'\+YG-/\ B+T,SXC?
M\B3-_P!?EG_Z515LUC?$;_D29O\ K\L__2J*MFK?\->K_0A?&_1?J%%%%9EA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% 'S_\ M.^&-]GI7B>VBRT9-G<L!_"<M&3]#O&?<5\ZCG%?>?BOP]:^
M*_"NH:)? >5>1% Q'W&ZJP]PP!_"OA*]M)M/U"XL[I-D]O*T4J_W64D$?F#0
M(["]=+AK"X496XME8YY^900?Y51\N>WFQ("ZY!SU'T_*K-M+YOAO35CV[U\Q
M"6[#=4\$T:1L6^?!R"1PV.U2([WPY=Q:UIMS:7<P!B52G&-IQU'Y=!Z5K:?$
MUOF&4;6C.#7FZ23Q7"BV7D+ESN!X/8?A7J.EXU/1(]20YPQ1N.J@X!_0_I45
M(\RN;T9V=F7H.7!K:L3\PK'MN#6O9$;ACUK!'0SJ+,_**\T\>:BMO\0+:W$H
M4R6\1(+8Y#N1_GWKT2*98H2SG  SUKQJ0/XS^+MW<0$_9;55@#8R, 98_J:W
M1E+8Y?Q1806FO7@MDV1N_F;>P+ $_J:YN"Z>QU ,HQ&P^<?UKK/$C^?JMY(.
M093CW X'\JY.5=VH+'_L$U#W9MKRHZ^TN%EB5D;((X-6P2,=ZX[3=0:QG$$O
M,1;@G^'_ .M770R+(HQ6$E8M2N6HY2JG!K,U3,L;9YXJ]].E5;M<H<U/4;+7
M@*Y5)'M92J;9&Z@98%0?3VKM'4.[>4OENJ"12N.>OX=Z\[\/JW]M0QHF6DF5
M0S9VJ3P"<'WKOXOMT]VQ^SK'^Z)0,W7!(P>.YX_*O1@[Q1YLU:1%',;O7K6*
M4[&ZR*CX#_*>H ]OTKFK:6>UO+B.=I%!F;<GS8 )YX!JU<7=W9ZQ:7<=M,S
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MO5_H0OC?HOU"BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M< 'BOHK5_AJYT*^N]4D0+#;NX"#G('K7SG(?F-.SOJ.^@"@C-,W =374^$O
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MRNI!+,P"K]>*3$9%L"LJIDLI7*DL/_U"K4+R,I\V-D!<;0%&">G7':O8-'^
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MQHDI_P"VB?\ Q51'X:>, ?\ D!S?@Z?XU],XI0*7LD'.SYF/P^\71CG0KK\
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M9%:=HNZ51Z5SEG7EM]C:CL :U+!?E%94 W6D'H,UM6*_**U EU0XT\^Y K"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\
M I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0
MQZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T
M^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\
M^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_P
MG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]
M?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T
M_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\
M I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0
MQZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T
M^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\
M^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_P
MG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]
M?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T
M_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\
M I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0
MQZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T
M^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\
M^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_P
MG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]
M?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T
M_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\
M I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0
MQZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T
M^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\
M^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_P
MG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]
M?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T
M_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\
M I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0
MQZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T
M^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_PG?A3_H8],_\  I/\:Z?[#:?\
M^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]?,YC_A._"G_0QZ9_X%)_C1_P
MG?A3_H8],_\  I/\:Z?[#:?\^L/_ '[%'V&T_P"?6'_OV*+T^S^__@!:IW7]
M?,YC_A._"G_0QZ9_X%)_C2'QSX2;KXBTL_\ ;TG^-=1]AM/^?6'_ +]BC[#:
M?\^L/_?L47I]G]__   M4[K^OF<R/'?A,?\ ,QZ9_P"!2?XUF:OXJ\,:@Z&/
MQ+I*A1_%=K7<_8;3_GUA_P"_8H^PVG_/K#_W[%.]/L_O_P" %I]U_7S/*Y=>
M\.J?^1@TQO\ =N5-0'Q%X>_Z#=A_X$+_ (UZW]AM/^?6'_OV*/L-I_SZP_\
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MY]8?^_8H^PVG_/K#_P!^Q1ST^S^__@!:?=?U\SS_ /X3/PU_T'M._P# E?\
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;_HM:O?8;3_GUA_[]BI^G2E*<7&R0XQE>[/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140571862364256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 27, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">GENPREX, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Jun. 27,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-38244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">90-0772347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">3300 Bee Cave Road, #650-227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">78746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">537-7997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GNPX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001595248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M%'.NA;)%%Q(HW5(@7"HOM:I:Z^1LG9NZ;BH#I1.ELV*KD84!/*(T&:N=-/H
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " "G1=M8EXJ[',
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MA1H#V#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ IT7;6 =!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "G1=M8
MJ:9NQN\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " "G1=M8F5R<(Q &  "<)P  $P              @ '-
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *=%VUA./+I_1 0
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M2P$"% ,4    " "G1=M8)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "G1=M899!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="gnpx20240507_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gnpx.com/20240627/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>gnpx-20240627.xsd</File>
    <File>gnpx-20240627_def.xml</File>
    <File>gnpx-20240627_lab.xml</File>
    <File>gnpx-20240627_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="gnpx20240507_8k.htm">gnpx20240507_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gnpx20240507_8k.htm": {
   "nsprefix": "gnpx",
   "nsuri": "http://www.gnpx.com/20240627",
   "dts": {
    "schema": {
     "local": [
      "gnpx-20240627.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "gnpx-20240627_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gnpx-20240627_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gnpx-20240627_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "gnpx20240507_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.gnpx.com/20240627/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gnpx20240507_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gnpx20240507_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.gnpx.com/20240627/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001437749-24-021339-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-021339-xbrl.zip
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MRMJ*%/4!PE3_G!<NP2=<(T] '!_BVC> (E12:([F#*2F-R"%KII8T5% /#3
M,P2AVBS++S0;OY@8S]8ZE';<_$L-]%=@9G'D2-:>"#%9^"WXF"D^NZ297=+,
MYYLT<TW]S2=-A;E]8ATQJ2#+QW_ZN(EUGZ@6[W-*#7KOO1MA-&#5PW$M,&<#
MI@HI0W;I+\B%@->H(.U!%XL.KNJ[H_?')\__O8RH*@)3] Q!^732RZP'XZ#'
MIR2\&%V)(3_:E%_ S';0(49(<?Z_-.Q(-R;PF9X6MBQS!T5Z-R]II8&>;L<T
MH[>D(IVK?^AT?J".\D%SUVNSJ(HZ]@"F=^<F)2N;)E^G>GS/@PC@L #:$=7"
M[0NY*T-A?_'WTO+^VM[:F#S+,*5>[#=PO6**B<1?!WW:]94%NL23-N#8:_Z4
M<$YCB9%22&Q*'NS27=QO*^_A_*BFCN#F"H*[+YZ-[FVH(^AU1R'(^5!KKX$U
M78^HRHNV#0=K>X[X4\NI*TVP6:R]70;86FMOW3D3G*9UO2S",'_L(*968_TX
M17R9S'9X?U_^:+9$/BXUKI OS\(\ ?E*?(>PQP0'V2O_(8\,F !&[[G=FBX:
M8HX2,W(@Z<)_4$DA"9# ZI!W/'_YXD2E=8AYYTTSGZ?&U1$",M$<2GZ!'\#.
M@MA9$#L+8I=V_\G9_7O/D[L96N)_#@N-VXI/7^\9>+!OZ>CFIS980[/\DA0F
MSYY1#3?E'ITH*>6RKRI/7,M.YIU9+L]G=Y=XZZYLQ'!_@VX">]5T#"C]:XPN
MD@7[NE@S- B[ AN*GURB#V@C"5!0C9HQSB FCHY"1!-W>/L$>F'C593LA[;W
M! D,Z;?#?0T$F7%.HN)ZO]&7IVJ<79\=:$O5U+8#79[U$+%RKMC_2AOZ\&'@
M&?Q!)Q-':J4))3O=UM726SV@U9DS[ZUDJ"?&F)KA@;>[G3/@9R;-?><C=3:S
M+<@9MU;A=@! _4-S#T>\W(I#D&%#-SF3I8!XXNED(TZM0^1#ICMPS#KED9Z>
M>P%*ILEBQMBDE7G/C;!0K(+Q1'G& 7PR)I#@4%C ^:%HPY8!UO6*23%\W%'Z
M.'8:Y3/:K<;+*_LE$(I2$^XT,EP5!,_*IIHFXPH1^,_]XM=E]TD"H[LT4N.&
M@$---W]S[<GZH)Z0#9XAZ9Z[*HXTJZS#0"*%WQS>2OY\3GX6/A4;,H%MZ>0.
M4ZGO;R.;;.EZ>.,Y:Y,;Z BD*9W'C M#&*R4&U[XT-,YG9H9+'%.RPGD5T$7
MYRG-)O;L9^P2$40R2;LS/@BNY&MYN#S,'3>_QKS>WYG7UP93X=CYG3;VM6I6
M8V,K,J\#[]9R-\C0GMYWU"\=;*ZSG[W?#P.ZV7(N36,8SQAW5!0H5+VLLXW]
MPP?JN"GCZW@BQ!_*=^$9D@VZ-]A[J-+I_?.ITPZ-M.@)LC*<^ GE*TVF%V)K
MMTMQJB>&I.P)8ZH+]'I5&=, *O<:F1X,Q'.>.!@#"W0:W6,W.JS?WF"X+Q_9
MH>F$7)!4XL9]&SW:H46TX"ONWM) OHONXD0KOXR'S=VNB!)(+76=<7P3J<T.
MG8UU&S(,MP^I)J6L3@.EG2?!8)^,8\R)8.ZA_-L6 "5XJ;TLK_=7Y/7^MH1U
M/F*M=)/VV?I,G05W XVVIVE)A[]&IO,C2:XW@8)5^<X4+""O/"P>@?=^;W8[
M-J2Z<[IMF=/M3W6+[3QBGY='[ \COW;TTP>W44\_)W[^PCJLI\L_%.#Y'<KG
M@Q7E\WT@4Y9_O846VH20!02<NT&8S+?T\%F=7?V4UL1D0(E3HJ1NRJA]?MKG
MI%J._,16D-5]XU:I\%L-\HAC"(L6#&W)(:2X$Z.M7+.++&;(>:\!<UO$U@+N
M+7FO FV39[-^->JLLLG:6%2.?(2P]81W/MG W=E%4OLP3M[U/J%8^JILT%9[
MW;L$(B+02->Y"C>KOMMP]K:'"_PD7DP^]SJ&1I[6265I6Y:/H:O)R#L*X .G
M\W,FRFTJ-' RIVP.]&Y1K>'R6<5_VZ! KAO8,DA-TTQ"J)O;K(@=TGCEEU+W
M&V>1_UU+JQTWXZ67YG7%6(3<F^AG'*=BK/E<M64CI@+?I*%A19U_&KUN?-YI
M4VW"N;Z.T00'G1A.ES$W>;W$HZ]<+YO5OM3;XOD,;2BFE@<=(RKX:@NLJ ^C
M3&RN1"4ZV5"(>NP+;X^#PMMGNM)?FD(RJER<#NS(%?72"M'AY$K=5"IUP6I&
M\\(F/7>&UI7-JWE3UZQ)?4]J":9L+''F?F$NWS\4I?1QM839BS*N\7<I?@XM
MZ*9DOO6I68&^L7W2:1MKVA@-8 <EL%T3.&N+WH+^2#T%U#D&GO4XJO7A/S>D
MS'+I!2NU JA1SUT#.Z?2/7_[YNO^Z,UK$NR:%<9W=.).67$_@N+^!@?IB-B!
MS6C&W, <_8 C:6Q>2W]Q$I, DP5W[3DD5Z$9QBZ3"AX46;NFB*S$RVCX;\\>
MVA,,AO3F]?_JF UB1[@BDID=2P-$M#ET05O?/=6W2F<?%M2?C+,71@T:-BRT
M /V#E.VH3CUK<Z!II-GW96*5((EP<@$Z(V5N[$BF:+L\^A&_DTS:'QOUI!>X
M<8/E6%-MSN7I_.R^:W[+)J+;1^A,[1*Z,73>&J[0I0Z<>[@L-JR*L=5A&'&N
M:1"(] L[<0C,+A7P)%B>H)ZIS?BHYQPQGM0%Q\&7BBI#8U+JQ5 U#S*3D;8[
M[1"A%W^M LL=!]]Q\%MS<&<QDZH$/\:-G%Q.MH<XHL$B88LLN-00U=%)+=.E
M7'O'\222,&>-S#<C9<>2#!<E^EDT@Z%EYG0I.M>)<V8-WW8)70VG$JX4FXF-
MV([KO-A[35"7Z@T^F83G]VA>BC[09>6\85>>?SNV9%#-N"!>O6!NRQU>N6+3
M5GDTH]5C W%T=NR!,7CQ$J,]:&9I@E5 M:S)&.? K1VWV1".):TW+[BCZ*3.
M(@<[?]8R:<?22)1.3=E4H(9%E<23%YS9TW2O9HA;]I2M(.H@[@*3O?)9S$4]
M=^&\=D?;LEN>1J^IRF4@3[]*W@?C2VS=FM'"_F[VN0O)[$(RNY#,=H1DME:K
M^" *Q$UKM[QT-S.>ST$Y<.VC;ZD;O#713&=.8*RZ4627Q#Z+Y0,KWAQ3<3\Z
M_S!$R>N3T>G]T[/7PR$P.TA ;B 0T ?,BK[C \-](K0[AVGU]#[=Q&@>[F7'
MSX8P$6S)0A'R#2@!)-)9[;]9SY IM;*S50]8WW$/++$;: ;+/O+6Z!&,!UA5
M5R3^IX6>L,L7* R=XDGNC)/E3D<:J-#8X:0QL=.T=,YA\ B_B+[).]N!W+&I
MB;+,Z-$9)SRF-C+>H^60W?E'Q8M/>H:K0G6@2-?<Z&[PBE?$$!.Q24EEX5)'
M?C5RH^0Z48%$.Q&5Q"D,7AMT)K(L<Z:SG+/GHZ2AH$' D/XJQMBG#O9X^U@W
MU:Q0)!G3#:078G](DYT%X/VYYCEV:;03T\?!9FR-3E>!KA4=H&JL C>BO5"C
MNK*NZQ[OW R- Y75U,:+>NQZ%C35O[[) 0<35ULH=$!:0\>N$!5R$)L)+ ^R
M#* JN][=V ]'SL9?OY$SQRZ>-T%4L&LRO[R7Y+@%R.67G 4%\:\">-PO+5[Q
M7!=TEHH0EAVI%$3V-6+GOLF&]#&7X*4GI%7P8;%'&5E8.I>'L,,"@W<*KUZ.
M?EM-"&E$3-_WIJ>GOW4-[5%'GI43&EMP 9O<37#W!MQAB;/CX"Q!&TNN1A!P
M=VWJ9>C-=*2V-7#[]>&[;2,P%0:8Y!&SE4Z^!1+SQZ7AP(CSOXG0(%629K'(
M:Y>7(C$;;AHV,Z1$SQ:\:A<VKDDNWO-IJ#]F.*NE\[F^)6EEI\2=3O*I27Q(
M[H@MI=[2J .+EY[UULQT06?^K<-".D)WBRD+K7>ZG%U8^@@#*$-VHG$ 5/Q
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MI5N1D.*ZM\"_(L0(:")(\U?9!6#OI]K)%BP>(Y'>??4.EMU\GC@/MK/I'<0
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M+EX29=*'@$M+6YD1;9!5_\7/?P%02P,$%     @ IT7;6%LOG*?9!   Y2P
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M _HI\$0FXQMG2S&3\VB.Z%I["!C1CGAVY:2.U<3^2E!2P*RPW6G.>K(SCLA
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M9IZDI14[0'8Z>)*76NPZG>TXQ!>20,,_/YU*U(_Z9R_<^0]02P,$%     @
MIT7;6*>#"I9+$   )6X  !,   !G;G!X,C R-# U,#=?.&LN:'1M[1UK<]HZ
M]O/MK]!R=V_3F1AL'N&1-#LI(;ELVR1#Z&QGO^P(6X!NC<V5Y 3VU^\YD@TV
M@0:2%)+>=-I);!U)1T?G[2/UZ)^3D4]NF) \#-Z_=?+V6\("-_1X,'C_]N2Z
MV6Z__>?QFZ.A C  #>3[W%"I<:-0N+V]S=^6\J$8%)QZO5Z8($S. #4$ZV<
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M,C R-# V,C<N>'-D4$L! A0#%     @ IT7;6%LOG*?9!   Y2P  !4
M         ( !E3,  &=N<'@M,C R-# V,C=?9&5F+GAM;%!+ 0(4 Q0    (
M *=%VUB$Z.CI^@4  $,\   5              "  :$X  !G;G!X+3(P,C0P
M-C(W7VQA8BYX;6Q02P$"% ,4    " "G1=M8&TEHC'4$  !]+0  %0
M        @ './@  9VYP>"TR,#(T,#8R-U]P<F4N>&UL4$L! A0#%     @
MIT7;6*>#"I9+$   )6X  !,              ( !=D,  &=N<'@R,#(T,#4P
>-U\X:RYH=&U02P4&      8 !@"$ 0  \E,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>gnpx20240507_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gnpx-20240627.xsd" xlink:type="simple"/>
    <context id="d20248K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001595248</identifier>
        </entity>
        <period>
            <startDate>2024-06-27</startDate>
            <endDate>2024-06-27</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20248K" id="ixv-298">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20248K" id="ixv-299">0001595248</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20248K" id="ixv-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20248K" id="ixv-34">2024-06-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20248K" id="ixv-40">GENPREX, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20248K" id="ixv-52">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20248K" id="ixv-57">001-38244</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20248K" id="ixv-62">90-0772347</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20248K" id="ixv-83">3300 Bee Cave Road, #650-227</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20248K" id="ixv-88">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20248K" id="ixv-93">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20248K" id="ixv-103">78746</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20248K" id="ixv-116">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20248K" id="ixv-121">537-7997</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20248K" id="ixv-309">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20248K" id="ixv-310">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20248K" id="ixv-311">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20248K" id="ixv-312">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20248K" id="ixv-313">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20248K" id="ixv-314">GNPX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20248K" id="ixv-315">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20248K" id="ixv-316">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
